1.1 	A bill for an act
1.2 	relating to cannabis; transferring enforcement of edible cannabinoid products to 
1.3 	the Office of Cannabis Management; clarifying workplace testing for cannabis; 
1.4 	making technical changes related to the taxation of cannabis and related products; 
1.5 	replacing medical cannabis licenses with endorsements; establishing a petition 
1.6 	process to designate cannabinoids as nonintoxicating or approved for use in 
1.7 	lower-potency hemp edibles; authorizing lower-potency hemp edibles to contain 
1.8 	certain artificially derived cannabinoids created in making delta-9 
1.9 	tetrahydrocannabinol; allowing testing of certain hemp products to be performed 
1.10 	by labs meeting accreditation standards regardless of licensing status; authorizing 
1.11 	patients enrolled in the registry program to obtain cannabis flower from registered 
1.12 	designated caregivers; authorizing registered designated caregivers to cultivate 
1.13 	cannabis plants on behalf of patients enrolled in the registry program; authorizing 
1.14 	the Office of Cannabis Management to recall certain cannabis and related products; 
1.15 	transferring the duties of the medical cannabis program to the Office of Cannabis 
1.16 	Management on July 1, 2025; authorizing the appointment of deputy directors; 
1.17 	clarifying the process for transfer of certain licenses; providing for license 
1.18 	preapproval; removing the requirement that local governments perform certain 
1.19 	inspections; removing the requirement that license applications be scored based 
1.20 	on identified criteria and requiring that license applications be assessed based on 
1.21 	certain minimum criteria; requiring employees of cannabis businesses to meet 
1.22 	certain background check requirements; establishing social equity licenses; limiting 
1.23 	the number of certain licenses that can be made available in an application period; 
1.24 	providing for the conversion of a registration to sell certain hemp-derived products 
1.25 	into a hemp business license; providing for a cannabis research license 
1.26 	classification; authorizing the Office of Cannabis Management to adjust limits on 
1.27 	cultivation area; permitting certain businesses to transport cannabis and related 
1.28 	products between facilities operated by the business; replacing the prohibition on 
1.29 	certain sales of lower-potency hemp products with a prohibition on selling to an 
1.30 	obviously intoxicated person; providing for enforcement of unlicensed businesses 
1.31 	engaging in activities that require a license; making technical and conforming 
1.32 	changes;amending Minnesota Statutes 2022, sections 17.133, subdivision 1; 
1.33 	152.22, subdivisions 11, 14, by adding a subdivision; 152.25, subdivision 2; 152.27, 
1.34 	subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.28, subdivision 2; 152.29, 
1.35 	subdivision 3; 181.950, subdivision 10; 181.952, as amended; Minnesota Statutes 
1.36 	2023 Supplement, sections 3.9224, subdivision 1; 151.72, subdivisions 1, 2, 3, 4, 
1.37 	5a, 5b, 6, 7; 152.28, subdivision 1; 152.30; 181.951, subdivisions 4, 5, 8; 181.954, 
1.38 	subdivision 1; 342.01, subdivisions 14, 17, 19, 48, 50, 52, 54, 63, 64, 65, 66, by 
2.1 	adding subdivisions; 342.02, subdivisions 2, 3, 6; 342.03, subdivisions 1, 4; 342.06; 
2.2 	342.07, subdivision 3; 342.09, subdivision 3; 342.10; 342.11; 342.12; 342.13; 
2.3 	342.14; 342.15, by adding a subdivision; 342.17; 342.18, subdivisions 2, 3, by 
2.4 	adding subdivisions; 342.19, by adding a subdivision; 342.22; 342.24, subdivisions 
2.5 	1, 2; 342.28, subdivision 2, by adding subdivisions; 342.29, subdivision 4, by 
2.6 	adding a subdivision; 342.30, subdivision 4; 342.31, subdivision 4; 342.32, 
2.7 	subdivision 4; 342.35, subdivision 1; 342.37, subdivision 1; 342.40, subdivision 
2.8 	7; 342.41, subdivision 3; 342.46, subdivision 8; 342.51; 342.515, subdivision 1, 
2.9 	by adding a subdivision; 342.52, subdivisions 1, 2, 3, 4, 5, 9, 11; 342.53; 342.54; 
2.10 	342.55, subdivisions 1, 2; 342.56, subdivisions 1, 2; 342.57, subdivisions 1, 2, 4; 
2.11 	342.60; 342.61, subdivisions 1, 4, 5; 342.62, by adding a subdivision; 342.63, 
2.12 	subdivisions 2, 3, 6; 342.64, subdivision 1; 342.73, subdivision 4; 342.80; Laws 
2.13 	2023, chapter 63, article 1, sections 2; 51; 52; 53; 54; 55; 56; 57; 58; 59; 61; article 
2.14 	6, sections 10; 73; proposing coding for new law in Minnesota Statutes, chapter 
2.15 	342; repealing Minnesota Statutes 2022, sections 152.22, subdivision 3; 152.36; 
2.16 	Minnesota Statutes 2023 Supplement, sections 342.01, subdivision 28; 342.18, 
2.17 	subdivision 1; 342.27, subdivision 13; 342.29, subdivision 9; 342.47; 342.48; 
2.18 	342.49; 342.50; Laws 2023, chapter 63, article 7, sections 4; 6.
2.19 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.20 	Section 1. Minnesota Statutes 2023 Supplement, section 3.9224, subdivision 1, is amended 
2.21 	to read:
2.22 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
2.23 	meanings given.
2.24 	(b) "Medical cannabis law" or "medical cannabis program" means the regulatory 
2.25 	framework for cultivation, production, distribution, and sale of cannabis to qualifying 
2.26 	patients for therapeutic use in the treatment of a qualifying condition.
2.27 	(c) "Medical cannabis flower" means cannabis flower approved for sale under the medical 
2.28 	cannabis law of a Minnesota Tribal government or under a compact entered into under this 
2.29 	section.
2.30 	(d) "Medical cannabis product" means a cannabis product approved for sale under the 
2.31 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.32 	under this section.
2.33 	(e) "Medical cannabis business" means a medical cannabis cultivator, processor, or 
2.34 	retailer business with a medical cannabis endorsement.
2.35 	(f) "Medical cannabis industry" means every item, product, person, process, action, 
2.36 	business, or other thing or activity related to medical cannabis flower or medical cannabis 
2.37 	products and subject to regulation under the law of a Minnesota Tribal government or under 
2.38 	a compact entered into under this section.
2.39 	(g) "Cannabis product" means any of the following:
3.1 	(1) cannabis concentrate;
3.2 	(2) a product infused with cannabinoids, whether artificially derived, or extracted or 
3.3 	derived from cannabis plants or cannabis flower, including but not limited to 
3.4 	tetrahydrocannabinol; or
3.5 	(3) any other product that contains cannabis concentrate.
3.6 	(h) "Minnesota Tribal governments" means the following federally recognized Indian 
3.7 	Tribes located in Minnesota:
3.8 	(1) Bois Forte Band;
3.9 	(2) Fond Du Lac Band;
3.10 	(3) Grand Portage Band;
3.11 	(4) Leech Lake Band;
3.12 	(5) Mille Lacs Band;
3.13 	(6) White Earth Band;
3.14 	(7) Red Lake Nation;
3.15 	(8) Lower Sioux Indian Community;
3.16 	(9) Prairie Island Indian Community;
3.17 	(10) Shakopee Mdewakanton Sioux Community; and
3.18 	(11) Upper Sioux Indian Community.
3.19 	(i) "Tribal medical cannabis business" means a medical cannabis business licensed by 
3.20 	a Minnesota Tribal government, including the business categories identified in paragraph 
3.21 	(e), as well as any others that may be provided under the law of a Minnesota Tribal 
3.22 	government.
3.23 	(j) "Tribally regulated land" means:
3.24 	(1) all land held in trust by the United States for the benefit of a Minnesota Tribal 
3.25 	government ("trust land");
3.26 	(2) all land held by a Minnesota Tribal government in restricted fee status; and
3.27 	(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal 
3.28 	government that is subject to the civil regulatory jurisdiction of the Tribal government. For 
3.29 	the purposes of this section, land that is subject to the civil regulatory jurisdiction of the 
3.30 	Tribal government includes:
4.1 	(i) trust land, or fee land held, including leased land, by the Tribe, entities organized 
4.2 	under Tribal law, or individual Indians; and
4.3 	(ii) land held, including leased land, by non-Indian entities or individuals who consent 
4.4 	to the civil regulation of the Tribal government or are otherwise subject to such regulation 
4.5 	under federal law.

4.6 	Sec. 2. Minnesota Statutes 2022, section 17.133, subdivision 1, is amended to read:
4.7 		Subdivision 1.Definitions. (a) For purposes of this section, the following terms have 
4.8 	the meanings given.
4.9 	(b) "Eligible farmer" means an individual who at the time that the grant is awarded:
4.10 	(1) is a resident of Minnesota who intends to acquire farmland located within the state 
4.11 	and provide the majority of the day-to-day physical labor and management of the farm;
4.12 	(2) grosses no more than $250,000 per year from the sale of farm products; and
4.13 	(3) has not, and whose spouse has not, at any time had a direct or indirect ownership 
4.14 	interest in farmland.
4.15 	(c) "Emerging farmer" means a farmer experiencing limited land access or limited market 
4.16 	access.
4.17 	(c) (d) "Farm down payment" means an initial, partial payment required by a lender or 
4.18 	seller to purchase farmland.
4.19 	(e) "Limited land access" means farming (1) under a lease or other rental arrangement 
4.20 	of no more than three years in duration when the person leasing or renting the land to the 
4.21 	farmer is not related to the farmer by blood or marriage, or (2) by renting land from an 
4.22 	incubator farm.
4.23 	(f) "Limited market access" means the majority of a farmer's annual farm product sales 
4.24 	are direct sales to the consumer.

4.25 	Sec. 3. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended 
4.26 	to read:
4.27 		Subdivision 1.Definitions. For the purposes of this section, the following terms have 
4.28 	the meanings given.
4.29 	(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant 
4.30 	or hemp plant parts with a chemical makeup that is changed after extraction to create a 
5.1 	different cannabinoid or other chemical compound by applying a catalyst other than heat 
5.2 	or light. Artificially derived cannabinoid includes but is not limited to any 
5.3 	tetrahydrocannabinol created from cannabidiol.
5.4 	(b) "Batch" means a specific quantity of a specific product containing cannabinoids 
5.5 	derived from hemp, including an edible cannabinoid product, that is manufactured at the 
5.6 	same time and using the same methods, equipment, and ingredients that is uniform and 
5.7 	intended to meet specifications for identity, strength, purity, and composition, and that is 
5.8 	manufactured, packaged, and labeled according to a single batch production record executed 
5.9 	and documented.
5.10 	(c) "Certified hemp" means hemp plants that have been tested and found to meet the 
5.11 	requirements of chapter 18K and the rules adopted thereunder.
5.12 	(d) "Commissioner" means the commissioner of health.
5.13 	(e) (d) "Distributor" means a person who sells, arranges a sale, or delivers a product 
5.14 	containing cannabinoids derived from hemp, including an edible cannabinoid product, that 
5.15 	the person did not manufacture to a retail establishment for sale to consumers. Distributor 
5.16 	does not include a common carrier used only to complete delivery to a retailer.
5.17 	(f) (e) "Edible cannabinoid product" means any product that is intended to be eaten or 
5.18 	consumed as a beverage by humans, contains a cannabinoid in combination with food 
5.19 	ingredients, and is not a drug.
5.20 	(g) (f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 
5.21 	3.
5.22 	(h) (g) "Label" has the meaning given in section 151.01, subdivision 18.
5.23 	(i) (h) "Labeling" means all labels and other written, printed, or graphic matter that are:
5.24 	(1) affixed to the immediate container in which a product regulated under this section 
5.25 	is sold;
5.26 	(2) provided, in any manner, with the immediate container, including but not limited to 
5.27 	outer containers, wrappers, package inserts, brochures, or pamphlets; or
5.28 	(3) provided on that portion of a manufacturer's website that is linked by a scannable 
5.29 	barcode or matrix barcode.
5.30 	(j) (i) "Matrix barcode" means a code that stores data in a two-dimensional array of 
5.31 	geometrically shaped dark and light cells capable of being read by the camera on a 
5.32 	smartphone or other mobile device.
6.1 	(k) (j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp 
6.2 	plants that do not produce intoxicating effects when consumed by any route of administration.
6.3 	(k) "Office" means the Office of Cannabis Management.
6.4 	(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and 
6.5 	pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp 
6.6 	plants, or hemp plant parts and is instead created or produced by chemical or biochemical 
6.7 	synthesis.

6.8 	EFFECTIVE DATE. This section is effective July 1, 2024.

6.9 	Sec. 4. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended 
6.10 	to read:
6.11 		Subd. 2.Scope. (a) This section applies to the sale of any product that contains 
6.12 	cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended 
6.13 	for human or animal consumption by any route of administration.
6.14 	(b) This section does not apply to any product dispensed by a registered medical cannabis 
6.15 	manufacturer pursuant to sections 152.22 to 152.37.
6.16 	(c) The commissioner office must have no authority over food products, as defined in 
6.17 	section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from 
6.18 	hemp.

6.19 	EFFECTIVE DATE. This section is effective July 1, 2024.

6.20 	Sec. 5. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 3, is amended 
6.21 	to read:
6.22 		Subd. 3.Sale of cannabinoids derived from hemp. (a) Notwithstanding any other 
6.23 	section of this chapter, a product containing nonintoxicating cannabinoids, including an 
6.24 	edible cannabinoid product, may be sold for human or animal consumption only if all of 
6.25 	the requirements of this section are met, provided that. A product sold for human or animal 
6.26 	consumption does must not contain more than 0.3 percent of any tetrahydrocannabinol and 
6.27 	an edible cannabinoid product does must not contain an amount of any tetrahydrocannabinol 
6.28 	that exceeds the limits established in subdivision 5a, paragraph (f).
6.29 	(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid 
6.30 	product, may be sold for human or animal consumption only if it is intended for application 
7.1 	externally to a part of the body of a human or animal. Such a product must not be 
7.2 	manufactured, marketed, distributed, or intended to be consumed:
7.3 	(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or 
7.4 	vapor from the product;
7.5 	(2) through chewing, drinking, or swallowing; or
7.6 	(3) through injection or application to a mucous membrane or nonintact skin.
7.7 	(c) No other substance extracted or otherwise derived from hemp may be sold for human 
7.8 	consumption if the substance is intended:
7.9 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
7.10 	of disease in humans or other animals; or
7.11 	(2) to affect the structure or any function of the bodies of humans or other animals.
7.12 	(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise 
7.13 	derived from hemp may be sold to any individual who is under the age of 21.
7.14 	(e) Products that meet the requirements of this section are not controlled substances 
7.15 	under section 152.02.
7.16 	(f) Products may be sold for on-site consumption provided that if all of the following 
7.17 	conditions are met:
7.18 	(1) the retailer must also hold an on-sale license issued under chapter 340A;
7.19 	(2) products, other than products that are intended to be consumed as a beverage, must 
7.20 	be served in original packaging, but may be removed from the products' packaging by 
7.21 	customers and consumed on site;
7.22 	(3) products must not be sold to a customer who the retailer knows or reasonably should 
7.23 	know is intoxicated;
7.24 	(4) products must not be permitted to be mixed with an alcoholic beverage; and
7.25 	(5) products that have been removed from packaging must not be removed from the 
7.26 	premises.
7.27 	(g) Edible cannabinoid products that are intended to be consumed as a beverage may be 
7.28 	served outside of the products' packaging if the information that is required to be contained 
7.29 	on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.

7.30 	EFFECTIVE DATE. This section is effective July 1, 2024.

8.1 	Sec. 6. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended 
8.2 	to read:
8.3 		Subd. 4.Testing requirements. (a) A manufacturer of a product regulated under this 
8.4 	section must submit representative samples of each batch of the product to an independent, 
8.5 	accredited laboratory in order to certify that the product complies with the standards adopted 
8.6 	by the board on or before July 1, 2023, or the standards adopted by the commissioner office. 
8.7 	Testing must be consistent with generally accepted industry standards for herbal and botanical 
8.8 	substances, and, at a minimum, the testing must confirm that the product:
8.9 	(1) contains the amount or percentage of cannabinoids that is stated on the label of the 
8.10 	product;
8.11 	(2) does not contain more than trace amounts of any mold, residual solvents or other 
8.12 	catalysts, pesticides, fertilizers, or heavy metals; and
8.13 	(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.
8.14 	(b) A manufacturer of a product regulated under this section must disclose all known 
8.15 	information regarding pesticides, fertilizers, solvents, or other foreign materials applied to 
8.16 	industrial hemp or added to industrial hemp during any production or processing stages of 
8.17 	any batch from which a representative sample has been sent for testing, including any 
8.18 	catalysts used to create artificially derived cannabinoids. The disclosure must be made to 
8.19 	the laboratory performing testing or sampling and, upon request, to the commissioner office. 
8.20 	The disclosure must include all information known to the licensee manufacturer regardless 
8.21 	of whether the application or addition was made intentionally or accidentally, or by the 
8.22 	manufacturer or any other person.
8.23 	(c) Upon the request of the commissioner office, the manufacturer of the product must 
8.24 	provide the commissioner office with the results of the testing required in this section.
8.25 	(d) The commissioner office may determine that any testing laboratory that does not 
8.26 	operate formal management systems under the International Organization for Standardization 
8.27 	is not an accredited laboratory and require that a representative sample of a batch of the 
8.28 	product be retested by a testing laboratory that meets this requirement.
8.29 	(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or 
8.30 	possession of a certificate of analysis for such hemp, does not meet the testing requirements 
8.31 	of this section.

8.32 	EFFECTIVE DATE. This section is effective July 1, 2024.

9.1 	Sec. 7. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended 
9.2 	to read:
9.3 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
9.4 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
9.5 	must meet the requirements of this subdivision.
9.6 	(b) An edible cannabinoid product must not:
9.7 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
9.8 	animal, or fruit that appeals to children;
9.9 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
9.10 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
9.11 	commercially available candy or snack food item;
9.12 	(4) be substantively similar to a meat food product; poultry food product as defined in 
9.13 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
9.14 	7;
9.15 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
9.16 	by the United States Food and Drug Administration for use in food;
9.17 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
9.18 	product-specialized packaging of any commercially available food product; or
9.19 	(7) be packaged in a container that includes a statement, artwork, or design that could 
9.20 	reasonably mislead any person to believe that the package contains anything other than an 
9.21 	edible cannabinoid product.
9.22 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
9.23 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
9.24 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
9.25 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
9.26 	that is intended to be consumed as a beverage.
9.27 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
9.28 	as a beverage, is intended for more than a single use or contains multiple servings, each 
9.29 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
9.30 	serving size that appear on the edible cannabinoid product.
9.31 	(e) A label containing at least the following information must be affixed to the packaging 
9.32 	or container of all edible cannabinoid products sold to consumers:
10.1 	(1) the serving size;
10.2 	(2) the cannabinoid profile per serving and in total;
10.3 	(3) a list of ingredients, including identification of any major food allergens declared 
10.4 	by name; and
10.5 	(4) the following statement: "Keep this product out of reach of children."
10.6 	(f) An edible cannabinoid product must not contain more than five milligrams of any 
10.7 	tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product 
10.8 	that is intended to be consumed as a beverage, may not contain more than a total of 50 
10.9 	milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that 
10.10 	is intended to be consumed as a beverage may not contain more than two servings per 
10.11 	container.
10.12 	(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 
10.13 	tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an 
10.14 	artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing 
10.15 	any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and 
10.16 	HHC, unless the commissioner office authorizes use of the artificially derived cannabinoid 
10.17 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
10.18 	synthetic cannabinoids.
10.19 	(h) Every person selling edible cannabinoid products to consumers, other than products 
10.20 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
10.21 	products are displayed behind a checkout counter where the public is not permitted or in a 
10.22 	locked case.

10.23 	EFFECTIVE DATE. This section is effective July 1, 2024.

10.24 	Sec. 8. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended 
10.25 	to read:
10.26 		Subd. 5b.Registration; prohibitions. (a) On or before October 1, 2023, every person 
10.27 	selling edible cannabinoid products to consumers must register with the commissioner in 
10.28 	a form and manner established by the commissioner. After October 1, 2023, the sale of 
10.29 	edible cannabinoid products by a person that is not registered is prohibited.
10.30 	(a) Every person selling an edible cannabinoid product to a consumer must be registered 
10.31 	with the office. Existing registrations through the Department of Health must be transferred 
10.32 	to the office by July 1, 2024. All other persons required to register must register in a form 
11.1 	and manner established by the office. The sale of edible cannabinoid products by a person 
11.2 	who is not registered with the office is prohibited and subject to the penalties in section 
11.3 	342.09, subdivision 6; any applicable criminal penalty; and any other applicable civil or 
11.4 	administrative penalty.
11.5 	(b) The registration form must contain an attestation of compliance and each registrant 
11.6 	must affirm that it is operating and will continue to operate in compliance with the 
11.7 	requirements of this section and all other applicable state and local laws and ordinances.
11.8 	(c) The commissioner shall office must not charge a fee for registration under this 
11.9 	subdivision.

11.10 	EFFECTIVE DATE. This section is effective July 1, 2024.

11.11 	Sec. 9. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended 
11.12 	to read:
11.13 		Subd. 6.Noncompliant products; enforcement. (a) A product regulated under this 
11.14 	section, including an edible cannabinoid product, shall be considered a noncompliant product 
11.15 	if the product is offered for sale in this state or if the product is manufactured, imported, 
11.16 	distributed, or stored with the intent to be offered for sale in this state in violation of any 
11.17 	provision of this section, including but not limited to if:
11.18 	(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;
11.19 	(2) it has been produced, prepared, packed, or held under unsanitary conditions where 
11.20 	it may have been rendered injurious to health, or where it may have been contaminated with 
11.21 	filth;
11.22 	(3) its container is composed, in whole or in part, of any poisonous or deleterious 
11.23 	substance that may render the contents injurious to health;
11.24 	(4) it contains any food additives, color additives, or excipients that have been found by 
11.25 	the FDA to be unsafe for human or animal consumption;
11.26 	(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different 
11.27 	than the amount or percentage stated on the label;
11.28 	(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is 
11.29 	an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits 
11.30 	established in subdivision 5a, paragraph (f); or
11.31 	(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, 
11.32 	or heavy metals.
12.1 	(b) A product regulated under this section shall be considered a noncompliant product 
12.2 	if the product's labeling is false or misleading in any manner or in violation of the 
12.3 	requirements of this section.
12.4 	(c) The commissioner office may assume that any product regulated under this section 
12.5 	that is present in the state, other than a product lawfully possessed for personal use, has 
12.6 	been manufactured, imported, distributed, or stored with the intent to be offered for sale in 
12.7 	this state if a product of the same type and brand was sold in the state on or after July 1, 
12.8 	2023, or if the product is in the possession of a person who has sold any product in violation 
12.9 	of this section.
12.10 	(d) The commissioner office may enforce this section, including enforcement against a 
12.11 	manufacturer or distributor of a product regulated under this section, under sections 144.989 
12.12 	to 144.993 section 342.19.
12.13 	(e) The commissioner may enter into an interagency agreement with The office of 
12.14 	Cannabis Management and may enter into an interagency agreement with the commissioner 
12.15 	of agriculture to perform inspections and take other enforcement actions on behalf of the 
12.16 	commissioner office.

12.17 	EFFECTIVE DATE. This section is effective July 1, 2024.

12.18 	Sec. 10. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended 
12.19 	to read:
12.20 		Subd. 7.Violations; criminal penalties. (a) Notwithstanding section 144.99, subdivision 
12.21 	11, A person who does any of the following regarding a product regulated under this section 
12.22 	is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 
12.23 	364 days or to payment of a fine of not more than $3,000, or both:
12.24 	(1) knowingly alters or otherwise falsifies testing results;
12.25 	(2) intentionally alters or falsifies any information required to be included on the label 
12.26 	of an edible cannabinoid product; or
12.27 	(3) intentionally makes a false material statement to the commissioner office.
12.28 	(b) Notwithstanding section 144.99, subdivision 11, A person who does any of the 
12.29 	following on the premises of a registered retailer or another business that sells retail goods 
12.30 	to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for 
12.31 	not more than 364 days or to payment of a fine of not more than $3,000, or both:
13.1 	(1) sells an edible cannabinoid product knowing that the product does not comply with 
13.2 	the limits on the amount or types of cannabinoids that a product may contain;
13.3 	(2) sells an edible cannabinoid product knowing that the product does not comply with 
13.4 	the applicable testing, packaging, or labeling requirements; or
13.5 	(3) sells an edible cannabinoid product to a person under the age of 21, except that it is 
13.6 	an affirmative defense to a charge under this clause if the defendant proves by a 
13.7 	preponderance of the evidence that the defendant reasonably and in good faith relied on 
13.8 	proof of age as described in subdivision 5c.

13.9 	EFFECTIVE DATE. This section is effective July 1, 2024.

13.10 	Sec. 11. Minnesota Statutes 2022, section 152.22, subdivision 11, is amended to read:
13.11 		Subd. 11.Registered designated caregiver. "Registered designated caregiver" means 
13.12 	a person who:
13.13 	(1) is at least 18 years old;
13.14 	(2) does not have a conviction for a disqualifying felony offense;
13.15 	(3) (2) has been approved by the commissioner office to assist a patient who requires 
13.16 	assistance in administering medical cannabis or obtaining medical cannabis from a 
13.17 	distribution facility; and
13.18 	(4) (3) is authorized by the commissioner office to assist the patient with the use of 
13.19 	medical cannabis.

13.20 	EFFECTIVE DATE. This section is effective July 1, 2024.

13.21 	Sec. 12. Minnesota Statutes 2022, section 152.22, subdivision 14, is amended to read:
13.22 		Subd. 14.Qualifying medical condition. "Qualifying medical condition" means a 
13.23 	diagnosis of any of the following conditions:
13.24 	(1) Alzheimer's disease;
13.25 	(2) autism spectrum disorder that meets the requirements of the fifth edition of the 
13.26 	Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric 
13.27 	Association;
13.28 	(1) (3) cancer, if the underlying condition or treatment produces one or more of the 
13.29 	following:
13.30 	(i) severe or chronic pain;
14.1 	(ii) nausea or severe vomiting; or
14.2 	(iii) cachexia or severe wasting;
14.3 	(4) chronic motor or vocal tic disorder;
14.4 	(5) chronic pain;
14.5 	(2) (6) glaucoma;
14.6 	(3) (7) human immunodeficiency virus or acquired immune deficiency syndrome;
14.7 	(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
14.8 	(9) obstructive sleep apnea;
14.9 	(10) post-traumatic stress disorder;
14.10 	(4) (11) Tourette's syndrome;
14.11 	(5) (12) amyotrophic lateral sclerosis;
14.12 	(6) (13) seizures, including those characteristic of epilepsy;
14.13 	(7) (14) severe and persistent muscle spasms, including those characteristic of multiple 
14.14 	sclerosis;
14.15 	(8) (15) inflammatory bowel disease, including Crohn's disease;
14.16 	(16) irritable bowel syndrome;
14.17 	(17) obsessive-compulsive disorder;
14.18 	(18) sickle cell disease;
14.19 	(9) (19) terminal illness, with a probable life expectancy of under one year, if the illness 
14.20 	or its treatment produces one or more of the following:
14.21 	(i) severe or chronic pain;
14.22 	(ii) nausea or severe vomiting; or
14.23 	(iii) cachexia or severe wasting; or
14.24 	(10) (20) any other medical condition or its treatment approved by the commissioner.
14.25 	that is:
14.26 	(i) approved by a patient's health care practitioner; or
14.27 	(ii) if the patient is a veteran receiving care from the United States Department of Veterans 
14.28 	Affairs, certified under section 152.27, subdivision 3a.

15.1 	EFFECTIVE DATE. This section is effective July 1, 2024.

15.2 	Sec. 13. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
15.3 	read:
15.4 		Subd. 19.Veteran. "Veteran" means an individual who satisfies the requirements in 
15.5 	section 197.447 and is receiving care from the United States Department of Veterans Affairs.

15.6 	EFFECTIVE DATE. This section is effective July 1, 2024.

15.7 	Sec. 14. Minnesota Statutes 2022, section 152.25, subdivision 2, is amended to read:
15.8 		Subd. 2.Range of compounds and dosages; report. The commissioner office shall 
15.9 	review and publicly report the existing medical and scientific literature regarding the range 
15.10 	of recommended dosages for each qualifying condition and the range of chemical 
15.11 	compositions of any plant of the genus cannabis that will likely be medically beneficial for 
15.12 	each of the qualifying medical conditions. The commissioner office shall make this 
15.13 	information available to patients with qualifying medical conditions beginning December 
15.14 	1, 2014, and update the information annually every three years. The commissioner office
15.15 	may consult with the independent laboratory under contract with the manufacturer or other 
15.16 	experts in reporting the range of recommended dosages for each qualifying medical condition, 
15.17 	the range of chemical compositions that will likely be medically beneficial, and any risks 
15.18 	of noncannabis drug interactions. The commissioner office shall consult with each 
15.19 	manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list 
15.20 	of medical cannabis offered by a manufacturer shall be published on the Department of 
15.21 	Health Office of Cannabis Management website.

15.22 	EFFECTIVE DATE. This section is effective July 1, 2024.

15.23 	Sec. 15. Minnesota Statutes 2022, section 152.27, subdivision 1, is amended to read:
15.24 		Subdivision 1.Patient registry program; establishment. (a) The commissioner office
15.25 	shall establish a patient registry program to evaluate data on patient demographics, effective 
15.26 	treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting 
15.27 	on the benefits, risks, and outcomes regarding patients with a qualifying medical condition 
15.28 	engaged in the therapeutic use of medical cannabis.
15.29 	(b) The establishment of the registry program shall not be construed or interpreted to 
15.30 	condone or promote the illicit recreational use of marijuana.

15.31 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.1 	Sec. 16. Minnesota Statutes 2022, section 152.27, subdivision 2, is amended to read:
16.2 		Subd. 2.CommissionerOffice duties. (a) The commissioneroffice shall:
16.3 	(1) give notice of the program to health care practitioners in the state who are eligible 
16.4 	to serve as health care practitioners and explain the purposes and requirements of the 
16.5 	program;
16.6 	(2) allow each health care practitioner who meets or agrees to meet the program's 
16.7 	requirements and who requests to participate, to be included in the registry program to 
16.8 	collect data for the patient registry;
16.9 	(3) provide explanatory information and assistance to each health care practitioner in 
16.10 	understanding the nature of therapeutic use of medical cannabis within program requirements;
16.11 	(4) create and provide a certification to be used by a health care practitioner for the 
16.12 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
16.13 	condition and include in the certification an option for the practitioner to certify whether 
16.14 	the patient, in the health care practitioner's medical opinion, is developmentally or physically 
16.15 	disabled and, as a result of that disability, the patient requires assistance in administering 
16.16 	medical cannabis or obtaining medical cannabis from a distribution facility;
16.17 	(5) supervise the participation of the health care practitioner in conducting patient 
16.18 	treatment and health records reporting in a manner that ensures stringent security and 
16.19 	record-keeping requirements and that prevents the unauthorized release of private data on 
16.20 	individuals as defined by section 13.02;
16.21 	(6) develop safety criteria for patients with a qualifying medical condition as a 
16.22 	requirement of the patient's participation in the program, to prevent the patient from 
16.23 	undertaking any task under the influence of medical cannabis that would constitute negligence 
16.24 	or professional malpractice on the part of the patient; and
16.25 	(7) conduct research and studies based on data from health records submitted to the 
16.26 	registry program and submit reports on intermediate or final research results to the legislature 
16.27 	and major scientific journals. The commissioneroffice may contract with a third party to 
16.28 	complete the requirements of this clause. Any reports submitted must comply with section 
16.29 	152.28, subdivision 2.
16.30 	(b) The commissioneroffice may add a delivery method under section 152.22, subdivision 
16.31 	6, or add, remove, or modify a qualifying medical condition under section 152.22, subdivision 
16.32 	14, upon a petition from a member of the public or the task force on medical cannabis 
16.33 	therapeutic researchCannabis Advisory Council under section 342.03 or as directed by law. 
17.1 	The commissioner shall evaluate all petitions to add a qualifying medical condition or to 
17.2 	remove or modify an existing qualifying medical condition submitted by the task force on 
17.3 	medical cannabis therapeutic research or as directed by law and may make the addition, 
17.4 	removal, or modification if the commissioner determines the addition, removal, or 
17.5 	modification is warranted based on the best available evidence and research. If the 
17.6 	commissioneroffice wishes to add a delivery method under section 152.22, subdivision 6, 
17.7 	or add or remove a qualifying medical condition under section 152.22, subdivision 14, the 
17.8 	commissioneroffice must notify the chairs and ranking minority members of the legislative 
17.9 	policy committees having jurisdiction over health and public safety of the addition or removal
17.10 	and the reasons for its addition or removal, including any written comments received by 
17.11 	the commissioneroffice from the public and any guidance received from the task force on 
17.12 	medical cannabis researchCannabis Advisory Council under section 342.03, by January 
17.13 	15 of the year in which the commissioneroffice wishes to make the change. The change 
17.14 	shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

17.15 	EFFECTIVE DATE. This section is effective July 1, 2024.

17.16 	Sec. 17. Minnesota Statutes 2022, section 152.27, subdivision 3, is amended to read:
17.17 		Subd. 3.Patient application. (a) The commissioner office shall develop a patient 
17.18 	application for enrollment into the registry program. The application shall be available to 
17.19 	the patient and given to health care practitioners in the state who are eligible to serve as 
17.20 	health care practitioners. The application must include:
17.21 	(1) the name, mailing address, and date of birth of the patient;
17.22 	(2) the name, mailing address, and telephone number of the patient's health care 
17.23 	practitioner;
17.24 	(3) the name, mailing address, and date of birth of the patient's designated caregiver, if 
17.25 	any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse 
17.26 	will be acting as a caregiver;
17.27 	(4) a copy of the certification from the patient's health care practitioner that is dated 
17.28 	within 90 days prior to submitting the application that certifies that the patient has been 
17.29 	diagnosed with a qualifying medical condition; and
17.30 	(5) all other signed affidavits and enrollment forms required by the commissioner office
17.31 	under sections 152.22 to 152.37, including, but not limited to, the disclosure form required 
17.32 	under paragraph (c) (b).
18.1 	(b) The commissioner shall require a patient to resubmit a copy of the certification from 
18.2 	the patient's health care practitioner on a yearly basis and shall require that the recertification 
18.3 	be dated within 90 days of submission.
18.4 	(c) (b) The commissioner office shall develop a disclosure form and require, as a condition 
18.5 	of enrollment, all patients to sign a copy of the disclosure. The disclosure must include:
18.6 	(1) a statement that, notwithstanding any law to the contrary, the commissioner office, 
18.7 	or an employee of any state agency, may not be held civilly or criminally liable for any 
18.8 	injury, loss of property, personal injury, or death caused by any act or omission while acting 
18.9 	within the scope of office or employment under sections 152.22 to 152.37; and
18.10 	(2) the patient's acknowledgment that enrollment in the patient registry program is 
18.11 	conditional on the patient's agreement to meet all of the requirements of sections 152.22 to 
18.12 	152.37.

18.13 	EFFECTIVE DATE. This section is effective July 1, 2024.

18.14 	Sec. 18. Minnesota Statutes 2022, section 152.27, is amended by adding a subdivision to 
18.15 	read:
18.16 		Subd. 3a.Application procedure for veterans. (a) Beginning July 1, 2024, the office 
18.17 	shall establish an alternative certification procedure for veterans to enroll in the patient 
18.18 	registry program.
18.19 	(b) A patient who is a veteran receiving care from the United States Department of 
18.20 	Veterans Affairs and is seeking to enroll in the registry program must submit a copy of the 
18.21 	patient's veteran health identification card issued by the United States Department of Veterans 
18.22 	Affairs and an application established by the office to confirm that the veteran has been 
18.23 	diagnosed with a condition that may benefit from the therapeutic use of medical cannabis.

18.24 	EFFECTIVE DATE. This section is effective July 1, 2024.

18.25 	Sec. 19. Minnesota Statutes 2022, section 152.27, subdivision 4, is amended to read:
18.26 		Subd. 4.Registered designated caregiver. (a) The commissioner office shall register 
18.27 	a designated caregiver for a patient if the patient requires assistance in administering medical 
18.28 	cannabis or obtaining medical cannabis from a distribution facility and the caregiver has 
18.29 	agreed, in writing, to be the patient's designated caregiver. As a condition of registration as 
18.30 	a designated caregiver, the commissioner shall require the person to:
18.31 	(1) be at least 18 years of age;
19.1 	(2) agree to only possess the patient's medical cannabis for purposes of assisting the 
19.2 	patient; and
19.3 	(3) agree that if the application is approved, the person will not be a registered designated 
19.4 	caregiver for more than six registered patients at one time. Patients who reside in the same 
19.5 	residence shall count as one patient.
19.6 	(b) The commissioner shall conduct a criminal background check on the designated 
19.7 	caregiver prior to registration to ensure that the person does not have a conviction for a 
19.8 	disqualifying felony offense. Any cost of the background check shall be paid by the person 
19.9 	seeking registration as a designated caregiver. A designated caregiver must have the criminal 
19.10 	background check renewed every two years.
19.11 	(c) (b) Nothing in sections 152.22 to 152.37 shall be construed to prevent a person 
19.12 	registered as a designated caregiver from also being enrolled in the registry program as a 
19.13 	patient and possessing and using medical cannabis as a patient.

19.14 	EFFECTIVE DATE. This section is effective July 1, 2024.

19.15 	Sec. 20. Minnesota Statutes 2022, section 152.27, subdivision 6, is amended to read:
19.16 		Subd. 6.Patient enrollment. (a) After receipt of a patient's application, application fees,
19.17 	and signed disclosure, the commissioneroffice shall enroll the patient in the registry program 
19.18 	and issue the patient and patient's registered designated caregiver or parent, legal guardian, 
19.19 	or spouse, if applicable, a registry verification. The commissioneroffice shall approve or 
19.20 	deny a patient's application for participation in the registry program within 30 days after 
19.21 	the commissioneroffice receives the patient's application and application fee. The 
19.22 	commissioner may approve applications up to 60 days after the receipt of a patient's 
19.23 	application and application fees until January 1, 2016. A patient's enrollment in the registry 
19.24 	program shall only be denied if the patient:
19.25 	(1) does not have certification from a health care practitioner or, if the patient is a veteran 
19.26 	receiving care from the United States Department of Veterans Affairs, does not have the 
19.27 	documentation required under subdivision 3a that the patient has been diagnosed with a 
19.28 	qualifying medical condition;
19.29 	(2) has not signed and returned the disclosure form required under subdivision 3, 
19.30 	paragraph (c), to the commissioneroffice;
19.31 	(3) does not provide the information required;
20.1 	(4) has previously been removed from the registry program for violations of section 
20.2 	152.30 or 152.33; or
20.3 	(5) provides false information.
20.4 	(b) The commissioneroffice shall give written notice to a patient of the reason for 
20.5 	denying enrollment in the registry program.
20.6 	(c) Denial of enrollment into the registry program is considered a final decision of the 
20.7 	commissioner and is subject to judicial review under the Administrative Procedure Act 
20.8 	pursuant to chapter 14.
20.9 	(d) A patient's enrollment in the registry program may only be revoked upon the death 
20.10 	of the patient or if a patient violates a requirement under section 152.30 or 152.33.
20.11 	(e) The commissioneroffice shall develop a registry verification to provide to the patient, 
20.12 	the health care practitioner identified in the patient's application, and to the manufacturer. 
20.13 	The registry verification shall include:
20.14 	(1) the patient's name and date of birth;
20.15 	(2) the patient registry number assigned to the patient; and
20.16 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
20.17 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
20.18 	spouse will be acting as a caregiver.

20.19 	EFFECTIVE DATE. This section is effective July 1, 2024.

20.20 	Sec. 21. Minnesota Statutes 2023 Supplement, section 152.28, subdivision 1, is amended 
20.21 	to read:
20.22 		Subdivision 1.Health care practitioner duties. (a) Prior to a patient's enrollment in 
20.23 	the registry program, a health care practitioner shall:
20.24 	(1) determine, in the health care practitioner's medical judgment, whether a patient suffers 
20.25 	from a qualifying medical condition, and, if so determined, provide the patient with a 
20.26 	certification of that diagnosis;
20.27 	(2) advise patients, registered designated caregivers, and parents, legal guardians, or 
20.28 	spouses who are acting as caregivers of the existence of any nonprofit patient support groups 
20.29 	or organizations;
20.30 	(3) provide explanatory information from the commissioner to patients with qualifying 
20.31 	medical conditions, including disclosure to all patients about the experimental nature of 
21.1 	therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the 
21.2 	proposed treatment; the application and other materials from the commissioner; and provide 
21.3 	patients with the Tennessen warning as required by section 13.04, subdivision 2; and
21.4 	(4) agree to continue treatment of the patient's qualifying medical condition and report 
21.5 	medical findings to the commissioner.
21.6 	(b) Upon notification from the commissioner of the patient's enrollment in the registry 
21.7 	program, the health care practitioner shall:
21.8 	(1) participate in the patient registry reporting system under the guidance and supervision 
21.9 	of the commissioner;
21.10 	(2) report health records of the patient throughout the ongoing treatment of the patient 
21.11 	to the commissioner in a manner determined by the commissioner and in accordance with 
21.12 	subdivision 2;
21.13 	(3) determine, on a yearly basis every three years, if the patient continues to suffer from 
21.14 	a qualifying medical condition and, if so, issue the patient a new certification of that 
21.15 	diagnosis; and
21.16 	(4) otherwise comply with all requirements developed by the commissioner.
21.17 	(c) A health care practitioner may utilize telehealth, as defined in section 62A.673, 
21.18 	subdivision 2, for certifications and recertifications.
21.19 	(d) Nothing in this section requires a health care practitioner to participate in the registry 
21.20 	program.

21.21 	EFFECTIVE DATE. This section is effective July 1, 2024.

21.22 	Sec. 22. Minnesota Statutes 2022, section 152.28, subdivision 2, is amended to read:
21.23 		Subd. 2.Data. Data collected on patients by a health care practitioner and reported to 
21.24 	the patient registry, including data on patients who are veterans who receive care from the 
21.25 	United States Department of Veterans Affairs, are health records under section 144.291, 
21.26 	and are private data on individuals under section 13.02, but may be used or reported in an 
21.27 	aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research 
21.28 	conducted under section 152.25 or in the creation of summary data, as defined in section 
21.29 	13.02, subdivision 19.

21.30 	EFFECTIVE DATE. This section is effective July 1, 2024.

22.1 	Sec. 23. Minnesota Statutes 2022, section 152.29, subdivision 3, is amended to read:
22.2 		Subd. 3.Manufacturer; distribution. (a) A manufacturer shall require that employees 
22.3 	licensed as pharmacists pursuant to chapter 151 be the only employees to give final approval 
22.4 	for the distribution of medical cannabis to a patient. A manufacturer may transport medical 
22.5 	cannabis or medical cannabis products that have been cultivated, harvested, manufactured, 
22.6 	packaged, and processed by that manufacturer to another registered manufacturer for the 
22.7 	other manufacturer to distribute.
22.8 	(b) A manufacturer may distribute medical cannabis products, whether or not the products 
22.9 	have been manufactured by that manufacturer.
22.10 	(c) Prior to distribution of any medical cannabis, the manufacturer shall:
22.11 	(1) verify that the manufacturer has received the registry verification from the 
22.12 	commissioner office for that individual patient;
22.13 	(2) verify that the person requesting the distribution of medical cannabis is the patient, 
22.14 	the patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
22.15 	listed in the registry verification using the procedures described in section 152.11, subdivision 
22.16 	2d;
22.17 	(3) assign a tracking number to any medical cannabis distributed from the manufacturer;
22.18 	(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to 
22.19 	chapter 151 has consulted with the patient to determine the proper dosage for the individual 
22.20 	patient after reviewing the ranges of chemical compositions of the medical cannabis and 
22.21 	the ranges of proper dosages reported by the commissioner office. For purposes of this 
22.22 	clause, a consultation may be conducted remotely by secure videoconference, telephone, 
22.23 	or other remote means, so long as the employee providing the consultation is able to confirm 
22.24 	the identity of the patient and the consultation adheres to patient privacy requirements that 
22.25 	apply to health care services delivered through telehealth. A pharmacist consultation under 
22.26 	this clause is not required when a manufacturer is distributing medical cannabis to a patient 
22.27 	according to a patient-specific dosage plan established with that manufacturer and is not 
22.28 	modifying the dosage or product being distributed under that plan and the medical cannabis 
22.29 	is distributed by a pharmacy technician; only required:
22.30 	(i) if the patient is purchasing the medical cannabis flower or medical cannabinoid 
22.31 	product for the first time;
23.1 	(ii) if the patient purchases medical cannabis flower or a medical cannabinoid product 
23.2 	that the patient must administer using a different method than the patient's previous method 
23.3 	of administration;
23.4 	(iii) if the patient purchases medical cannabis flower or a medical cannabinoid product 
23.5 	with a cannabinoid concentration of at least double the patient's prior dosage; or
23.6 	(iv) upon the request of the patient; and
23.7 	(5) properly package medical cannabis in compliance with the United States Poison 
23.8 	Prevention Packing Act regarding child-resistant packaging and exemptions for packaging 
23.9 	for elderly patients, and label distributed medical cannabis with a list of all active ingredients 
23.10 	and individually identifying information, including:
23.11 	(i) the patient's name and date of birth;
23.12 	(ii) the name and date of birth of the patient's registered designated caregiver or, if listed 
23.13 	on the registry verification, the name of the patient's parent or legal guardian, if applicable;
23.14 	(iii) the patient's registry identification number;
23.15 	(iv) the chemical composition of the medical cannabis; and
23.16 	(v) the dosage; and
23.17 	(6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply 
23.18 	of the dosage determined for that patient.
23.19 	(d) A manufacturer shall require any employee of the manufacturer who is transporting 
23.20 	medical cannabis or medical cannabis products to a distribution facility or to another 
23.21 	registered manufacturer to carry identification showing that the person is an employee of 
23.22 	the manufacturer.
23.23 	(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only 
23.24 	to a patient age 21 or older, or to the registered designated caregiver, parent, legal guardian, 
23.25 	or spouse of a patient age 21 or older.

23.26 	EFFECTIVE DATE. This section is effective July 1, 2024.

23.27 	Sec. 24. Minnesota Statutes 2023 Supplement, section 152.30, is amended to read:
23.28 	152.30 PATIENT DUTIES.
23.29 	(a) A patient shall apply to the commissioner office for enrollment in the registry program 
23.30 	by submitting an application as required in section 152.27and an annual registration fee as 
23.31 	determined under section 152.35.
24.1 	(b) As a condition of continued enrollment, patients shall agree to:
24.2 	(1) continue to receive regularly scheduled treatment for their qualifying medical 
24.3 	condition from their health care practitioner; and
24.4 	(2) report changes in their qualifying medical condition to their health care practitioner.
24.5 	(c) A patient shall only receive medical cannabis from a registered manufacturer or 
24.6 	Tribal medical cannabis program but is not required to receive medical cannabis products 
24.7 	from only a registered manufacturer or Tribal medical cannabis program.

24.8 	EFFECTIVE DATE. This section is effective July 1, 2024.

24.9 	Sec. 25. Minnesota Statutes 2022, section 181.950, subdivision 10, is amended to read:
24.10 		Subd. 10.Positive test result. "Positive test result" means a finding of the presence of 
24.11 	drugs, cannabis, alcohol, or their metabolites in the sample tested in levels at or above the 
24.12 	threshold detection levels contained in the standards of one of the programs listed in section 
24.13 	181.953, subdivision 1.

24.14 	Sec. 26. Minnesota Statutes 2023 Supplement, section 181.951, subdivision 4, is amended 
24.15 	to read:
24.16 		Subd. 4.Random testing. An employer may request or require employees to undergo 
24.17 	cannabis testing or and drug and alcohol testing on a random selection basis only if (1) they 
24.18 	are employed in safety-sensitive positions, or (2) they are employed as professional athletes 
24.19 	if the professional athlete is subject to a collective bargaining agreement permitting random 
24.20 	testing but only to the extent consistent with the collective bargaining agreement.

24.21 	Sec. 27. Minnesota Statutes 2023 Supplement, section 181.951, subdivision 5, is amended 
24.22 	to read:
24.23 		Subd. 5.Reasonable suspicion testing. An employer may request or require an employee 
24.24 	to undergo cannabis testing and drug and alcohol testing if the employer has a reasonable 
24.25 	suspicion that the employee:
24.26 	(1) is under the influence of drugs, cannabis, or alcohol;
24.27 	(2) has violated the employer's written work rules prohibiting the use, possession, 
24.28 	impairment, sale, or transfer of drugs or alcohol, cannabis flower, cannabis products, 
24.29 	lower-potency hemp edibles, or hemp-derived consumer products while the employee is 
24.30 	working or while the employee is on the employer's premises or operating the employer's 
25.1 	vehicle, machinery, or equipment, provided if the work rules are in writing and contained 
25.2 	in the employer's written cannabis testing or drug and alcohol testing policy;
25.3 	(3) has sustained a personal injury, as that term is defined in section 176.011, subdivision 
25.4 	16, or has caused another employee to sustain a personal injury; or
25.5 	(4) has caused a work-related accident or was operating or helping to operate machinery, 
25.6 	equipment, or vehicles involved in a work-related accident.

25.7 	Sec. 28. Minnesota Statutes 2023 Supplement, section 181.951, subdivision 8, is amended 
25.8 	to read:
25.9 		Subd. 8.Limitations on cannabis testing. (a) An employer must not request or require 
25.10 	a job applicant to undergo cannabis testing solely for the purpose of determining the presence 
25.11 	or absence of cannabis as a condition of employment unless otherwise required by state or 
25.12 	federal law.
25.13 	(b) Unless otherwise required by state or federal law, an employer must not refuse to 
25.14 	hire a job applicant solely because the job applicant submits to a cannabis test or a drug and 
25.15 	alcohol test authorized by this section and the results of the test indicate the presence of 
25.16 	cannabis.
25.17 	(c) An employer must not request or require an employee or job applicant to undergo 
25.18 	cannabis testing on an arbitrary or capricious basis.
25.19 	(d) Cannabis testing authorized under paragraph (d) this section must comply with the 
25.20 	safeguards for testing employees provided in sections 181.953 and 181.954.

25.21 	Sec. 29. Minnesota Statutes 2022, section 181.952, as amended by Laws 2023, chapter 
25.22 	63, article 6, section 38, is amended to read:
25.23 	181.952 POLICY CONTENTS; PRIOR WRITTEN NOTICE.
25.24 		Subdivision 1.Contents of the policy. An employer's drug and alcohol and cannabis 
25.25 	testing policy must, at a minimum, set forth the following information:
25.26 	(1) the employees or job applicants subject to testing under the policy;
25.27 	(2) the circumstances under which drug or alcohol and cannabis testing may be requested 
25.28 	or required;
25.29 	(3) the right of an employee or job applicant to refuse to undergo drug and alcohol and 
25.30 	cannabis testing and the consequences of refusal;
26.1 	(4) any disciplinary or other adverse personnel action that may be taken based on a 
26.2 	confirmatory test verifying a positive test result on an initial screening test;
26.3 	(5) the right of an employee or job applicant to explain a positive test result on a 
26.4 	confirmatory test or request and pay for a confirmatory retest; and
26.5 	(6) any other appeal procedures available.
26.6 		Subd. 2.Notice. An employer shall provide written notice of its drug and alcohol testing 
26.7 	and cannabis testing policy to all affected employees upon adoption of the policy, to a 
26.8 	previously nonaffected employee upon transfer to an affected position under the policy, and 
26.9 	to a job applicant upon hire and before any testing of the applicant if the job offer is made 
26.10 	contingent on the applicant passing drug and alcohol testing. An employer shall also post 
26.11 	notice in an appropriate and conspicuous location on the employer's premises that the 
26.12 	employer has adopted a drug and alcohol testing and cannabis testing policy and that copies 
26.13 	of the policy are available for inspection during regular business hours by its employees or 
26.14 	job applicants in the employer's personnel office or other suitable locations.
26.15 		Subd. 3.Cannabis policy work rules. (a) Unless otherwise provided by state or federal 
26.16 	law, an employer is not required to permit or accommodate cannabis flower, cannabis 
26.17 	product, lower-potency hemp edible, or hemp-derived consumer product use, possession, 
26.18 	impairment, sale, or transfer while an employee is working or while an employee is on the 
26.19 	employer's premises or operating the employer's vehicle, machinery, or equipment.
26.20 	(b) An employer may only enact and enforce written work rules prohibiting cannabis 
26.21 	flower, cannabis product, lower-potency hemp edible, and hemp-derived consumer product 
26.22 	use, possession, impairment, sale, or transfer while an employee, is working or while an 
26.23 	employee is on the employer's premises or operating the employer's vehicle, machinery, or 
26.24 	equipment in a written policy that contains the minimum information required by this section.

26.25 	Sec. 30. Minnesota Statutes 2023 Supplement, section 181.954, subdivision 1, is amended 
26.26 	to read:
26.27 		Subdivision 1.Privacy limitations. A laboratory may only disclose to the employer test 
26.28 	result data regarding the presence or absence of drugs, cannabis, alcohol, or their metabolites 
26.29 	in a sample tested.

27.1 	Sec. 31. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended 
27.2 	to read:
27.3 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
27.4 	under this chapter:
27.5 	(1) cannabis microbusiness;
27.6 	(2) cannabis mezzobusiness;
27.7 	(3) cannabis cultivator;
27.8 	(4) cannabis manufacturer;
27.9 	(5) cannabis retailer;
27.10 	(6) cannabis wholesaler;
27.11 	(7) cannabis transporter;
27.12 	(8) cannabis testing facility;
27.13 	(9) cannabis event organizer;
27.14 	(10) cannabis delivery service; and
27.15 	(11) medical cannabis cultivator;
27.16 	(12) medical cannabis processor;
27.17 	(13) medical cannabis retailer; and
27.18 	(14) (11) medical cannabis combination business.

27.19 	Sec. 32. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended 
27.20 	to read:
27.21 		Subd. 17.Cannabis industry. "Cannabis industry" means every item, product, person, 
27.22 	process, action, business, or other thing related to cannabis plants, cannabis flower, and 
27.23 	cannabis products and subject to regulation under this chapter.

27.24 	Sec. 33. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended 
27.25 	to read:
27.26 		Subd. 19.Cannabis plant. "Cannabis plant" means all parts of the plant of the genus 
27.27 	Cannabis that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol 
27.28 	concentration of more than 0.3 percent on a dry weight basis, including but not limited to 
28.1 	a mother plant; a mature, flowering plant; an immature plant; or a seedling. Cannabis plant 
28.2 	does not include a hemp plant.

28.3 	Sec. 34. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
28.4 	subdivision to read:
28.5 		Subd. 31a.Endorsement. "Endorsement" means an authorization from the office to 
28.6 	conduct a specified operation activity.

28.7 	Sec. 35. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended 
28.8 	to read:
28.9 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
28.10 	that holds any of the following licenses:
28.11 	(1) cannabis microbusiness;
28.12 	(2) cannabis mezzobusiness;
28.13 	(3) cannabis cultivator;
28.14 	(4) cannabis manufacturer;
28.15 	(5) cannabis retailer;
28.16 	(6) cannabis wholesaler;
28.17 	(7) cannabis transporter;
28.18 	(8) cannabis testing facility;
28.19 	(9) cannabis event organizer;
28.20 	(10) cannabis delivery service;
28.21 	(11) lower-potency hemp edible manufacturer;
28.22 	(12) lower-potency hemp edible retailer; or
28.23 	(13) medical cannabis cultivator;
28.24 	(14) medical cannabis processor;
28.25 	(15) medical cannabis retailer; or
28.26 	(16) (13) medical cannabis combination business.

29.1 	Sec. 36. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 50, is amended 
29.2 	to read:
29.3 		Subd. 50.Lower-potency hemp edible. (a) "Lower-potency hemp edible" means any 
29.4 	product that:
29.5 	(1) is intended to be eaten or consumed as a beverage by humans;
29.6 	(2) contains hemp concentrate or an artificially derived cannabinoid, in combination 
29.7 	with food ingredients;
29.8 	(3) is not a drug;
29.9 	(4) consists of servings that contain no more than five milligrams of delta-9 
29.10 	tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol, or any 
29.11 	combination of those cannabinoids that does not exceed the identified amounts;
29.12 	(5) does not contain more than a combined total of 0.5 milligrams of all other 
29.13 	cannabinoids per serving;
29.14 	(6) does not contain an artificially derived cannabinoid other than delta-9 
29.15 	tetrahydrocannabinol;
29.16 	(7) (4) does not contain a cannabinoid derived from cannabis plants or cannabis flower; 
29.17 	and
29.18 	(8) (5) is a type of product approved for sale by the office or is substantially similar to 
29.19 	a product approved by the office, including but not limited to products that resemble 
29.20 	nonalcoholic beverages, candy, and baked goods.; and
29.21 	(6) meets either of the requirements in paragraph (b).
29.22 	(b) A lower-potency hemp edible includes:
29.23 	(1) a product that:
29.24 	(i) consists of servings that contain no more than five milligrams of delta-9 
29.25 	tetrahydrocannabinol; no more than 25 milligrams of cannabidiol, cannabigerol, cannabinol, 
29.26 	or cannabichromene; any other cannabinoid authorized by the office; or any combination 
29.27 	of those cannabinoids that does not exceed the identified amounts;
29.28 	(ii) does not contain more than a combined total of 0.5 milligrams of all other 
29.29 	cannabinoids per serving; and
29.30 	(iii) does not contain an artificially derived cannabinoid other than delta-9 
29.31 	tetrahydrocannabinol, except that a product may include artificially derived cannabinoids 
30.1 	created during the process of creating the delta-9 tetrahydrocannabinol that is added to the 
30.2 	product, if no artificially derived cannabinoid is added to the ingredient containing delta-9 
30.3 	tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially 
30.4 	derived cannabinoids is no less than 20 to one; or
30.5 	(2) a product that:
30.6 	(i) contains hemp concentrate processed or refined without increasing the percentage of 
30.7 	targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp 
30.8 	plant or hemp plant parts beyond the variability generally recognized for the method used 
30.9 	for processing or refining or by an amount needed to reduce the total THC in the hemp 
30.10 	concentrate; and
30.11 	(ii) consists of servings that contain no more than five milligrams of total THC.

30.12 	Sec. 37. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 52, is amended 
30.13 	to read:
30.14 		Subd. 52.Medical cannabinoid product. (a) "Medical cannabinoid product" means a 
30.15 	product that:
30.16 	(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with 
30.17 	cannabinoids, including but not limited to artificially derived cannabinoids; and
30.18 	(2) is provided to a patient enrolled in the registry program; a registered designated 
30.19 	caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a registered 
30.20 	designated caregiver, cannabis retailer, or medical cannabis retailercannabis business with 
30.21 	a medical cannabis retail endorsement to treat or alleviate the symptoms of a qualifying 
30.22 	medical condition.
30.23 	(b) A medical cannabinoid product must be in the form of:
30.24 	(1) liquid, including but not limited to oil;
30.25 	(2) pill;
30.26 	(3) liquid or oil for use with a vaporized delivery method;
30.27 	(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
30.28 	(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and 
30.29 	sublingual tablets;
30.30 	(6) edible products in the form of gummies and chews;
30.31 	(7) topical formulation; or
31.1 	(8) any allowable form or delivery method approved by the office.
31.2 	(c) Medical cannabinoid product does not include adult-use cannabis products or 
31.3 	hemp-derived consumer products.

31.4 	Sec. 38. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 54, is amended 
31.5 	to read:
31.6 		Subd. 54.Medical cannabis flower. "Medical cannabis flower" means cannabis flower 
31.7 	provided to a patient enrolled in the registry program or a visiting patient; a registered 
31.8 	designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a 
31.9 	registered designated caregiver, cannabis retailer, or medical cannabis businesscannabis 
31.10 	business with a medical cannabis retail endorsement to treat or alleviate the symptoms of 
31.11 	a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis 
31.12 	flower.

31.13 	Sec. 39. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 63, is amended 
31.14 	to read:
31.15 		Subd. 63.Qualifying medical condition. "Qualifying medical condition" means a 
31.16 	diagnosis of any of the following conditions:
31.17 	(1) Alzheimer's disease;
31.18 	(2) autism spectrum disorder that meets the requirements of the fifth edition of the 
31.19 	Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric 
31.20 	Association;
31.21 	(3) cancer, if the underlying condition or treatment produces one or more of the following:
31.22 	(i) severe or chronic pain;
31.23 	(ii) nausea or severe vomiting; or
31.24 	(iii) cachexia or severe wasting;
31.25 	(4) chronic motor or vocal tic disorder;
31.26 	(5) chronic pain;
31.27 	(6) glaucoma;
31.28 	(7) human immunodeficiency virus or acquired immune deficiency syndrome;
31.29 	(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
32.1 	(9) obstructive sleep apnea;
32.2 	(10) post-traumatic stress disorder;
32.3 	(11) Tourette's syndrome;
32.4 	(12) amyotrophic lateral sclerosis;
32.5 	(13) seizures, including those characteristic of epilepsy;
32.6 	(14) severe and persistent muscle spasms, including those characteristic of multiple 
32.7 	sclerosis;
32.8 	(15) inflammatory bowel disease, including Crohn's disease;
32.9 	(16) irritable bowel syndrome;
32.10 	(17) obsessive-compulsive disorder;
32.11 	(18) sickle cell disease;
32.12 	(19) terminal illness, with a probable life expectancy of under one year, if the illness or 
32.13 	its treatment produces one or more of the following:
32.14 	(i) severe or chronic pain;
32.15 	(ii) nausea or severe vomiting; or
32.16 	(iii) cachexia or severe wasting; or
32.17 	(20) any other medical condition or its treatment approved by the office. that is:
32.18 	(i) approved by a patient's health care practitioner; or
32.19 	(ii) if the patient is a veteran receiving care from the United States Department of Veterans 
32.20 	Affairs, certified under section 342.52, subdivision 3.

32.21 	EFFECTIVE DATE. This section is effective July 1, 2025.

32.22 	Sec. 40. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended 
32.23 	to read:
32.24 		Subd. 64.Registered designated caregiver. "Registered designated caregiver" means 
32.25 	an individual who:
32.26 	(1) is at least 18 years old;
32.27 	(2) is not disqualified for a criminal offense according to rules adopted pursuant to 
32.28 	section 342.15, subdivision 2;
33.1 	(3) (2) has been approved by the Division of Medical Cannabis office to assist a patient 
33.2 	with obtaining medical cannabis flower and medical cannabinoid products from a cannabis 
33.3 	retailer or medical cannabis retailer business with a medical cannabis retail endorsement
33.4 	and with administering medical cannabis flower and medical cannabinoid products; and
33.5 	(4) (3) is authorized by the Division of Medical Cannabis office to assist a patient with 
33.6 	the use of medical cannabis flower and medical cannabinoid products.

33.7 	Sec. 41. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended 
33.8 	to read:
33.9 		Subd. 65.Registry or registry program. "Registry" or "registry program" means the 
33.10 	patient registry established under this chapter listing patients; registered designated 
33.11 	caregivers; and any parent, legal guardian, or spouse of a patient who is authorized to perform 
33.12 	the following acts either as a patient or to assist a patient:
33.13 	(1) obtain medical cannabis flower, medical cannabinoid products, and medical cannabis 
33.14 	paraphernalia from a cannabis retailers and medical cannabis retailers business with a 
33.15 	medical cannabis retail endorsement; and
33.16 	(2) administer medical cannabis flower and medical cannabinoid products.

33.17 	Sec. 42. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended 
33.18 	to read:
33.19 		Subd. 66.Registry verification. "Registry verification" means the verification provided 
33.20 	by the Division of Medical Cannabis office that a patient is enrolled in the registry program 
33.21 	and that includes the patient's name, patient registry number, and, if applicable, the name 
33.22 	of the patient's registered designated caregiver or parent, legal guardian, or spouse.

33.23 	Sec. 43. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
33.24 	subdivision to read:
33.25 		Subd. 69a.Total THC.  "Total THC" means the sum of the percentage by weight of 
33.26 	tetrahydrocannabinolic acid multiplied by 0.877 plus the percentage by weight of all 
33.27 	tetrahydrocannabinols.

33.28 	Sec. 44. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended 
33.29 	to read:
33.30 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
34.1 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
34.2 	industry and hemp consumer industry;
34.3 	(2) to establish programming, services, and notification to protect, maintain, and improve 
34.4 	the health of citizens;
34.5 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
34.6 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
34.7 	(4) to establish and regularly update standards for product manufacturing, testing, 
34.8 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
34.9 	date;
34.10 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
34.11 	a disproportionate, negative impact from cannabis prohibition;
34.12 	(6) to issue and renew licenses;
34.13 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
34.14 	including the submission of fingerprints to the Federal Bureau of Investigation where 
34.15 	required by law and to obtain criminal conviction data for individuals seeking a license 
34.16 	from the office on the individual's behalf or as a cooperative member or director, manager, 
34.17 	or general partner of a business entity;
34.18 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
34.19 	and other documents of license holders to ensure compliance with all applicable laws and 
34.20 	rules;
34.21 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
34.22 	pursuant to the office's authority;
34.23 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
34.24 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
34.25 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
34.26 	of citizens;
34.27 	(12) to make loans and grants in aid to the extent that appropriations are made available 
34.28 	for that purpose;
34.29 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
34.30 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
34.31 	cannabis industry, and the hemp consumer industry;
34.32 	(14) to provide reports as required by law;
35.1 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
35.2 	cannabis products by persons 25 years of age or younger;
35.3 	(16) to determine, based on a review of medical and scientific literature, whether it is 
35.4 	appropriate to require additional health and safety warnings containing information that is 
35.5 	both supported by credible science and helpful to consumers in considering potential health 
35.6 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
35.7 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
35.8 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
35.9 	become pregnant, and the effects that use has on brain development for individuals under 
35.10 	the age of 25;
35.11 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
35.12 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
35.13 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
35.14 	products to customers;
35.15 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
35.16 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
35.17 	with the goals identified in subdivision 1; and
35.18 	(19) to order a person or business that cultivates cannabis flower or manufactures or 
35.19 	produces cannabis products, medical cannabinoid products, artificially derived cannabinoids, 
35.20 	lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived topical 
35.21 	products to recall any cannabis flower, product, or ingredient containing cannabinoids that 
35.22 	is used in a product if the office determines that the flower, product, or ingredient represents 
35.23 	a risk of causing a serious adverse incident; and
35.24 	(19) (20) to exercise other powers and authority and perform other duties required by 
35.25 	law.
35.26 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
35.27 	powers and duties until January 1, 2027:
35.28 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
35.29 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
35.30 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
35.31 	adult-use cannabis flower and adult-use cannabis products to customers; and
35.32 	(2) to permit, upon application to the office in the form prescribed by the director of the 
35.33 	office, a licensee under this chapter to perform any activity if such permission is substantially 
36.1 	necessary for the licensee to perform any other activity permitted by the applicant's license 
36.2 	and is not otherwise prohibited by law.

36.3 	Sec. 45. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 3, is amended 
36.4 	to read:
36.5 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
36.6 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
36.7 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
36.8 	15.039.
36.9 	(b) The following protections shall apply to employees who are transferred from the 
36.10 	Department of Health to the Office of Cannabis Management:
36.11 	(1) the employment status and job classification of a transferred employee shall not be 
36.12 	altered as a result of the transfer;
36.13 	(2) transferred employees who were represented by an exclusive representative prior to 
36.14 	the transfer shall continue to be represented by the same exclusive representative after the 
36.15 	transfer;
36.16 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
36.17 	continue in full force and effect for such transferred employees after the transfer;
36.18 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
36.19 	employees about any proposed changes affecting or relating to the transferred employees' 
36.20 	terms and conditions of employment to the extent such changes are not addressed in the 
36.21 	applicable collective bargaining agreement; and
36.22 	(5) for an employee in a temporary unclassified position transferred to the Office of 
36.23 	Cannabis Management, the total length of time that the employee has served in the 
36.24 	appointment shall include all time served in the appointment and the transferring agency 
36.25 	and the time served in the appointment at the Office of Cannabis Management. An employee 
36.26 	in a temporary unclassified position who was hired by a transferring agency through an 
36.27 	open competitive selection process in accordance with a policy enacted by Minnesota 
36.28 	Management and Budget shall be considered to have been hired through such process after 
36.29 	the transfer.
36.30 	(c) This subdivision is effective July 1, 2024.

37.1 	Sec. 46. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended 
37.2 	to read:
37.3 		Subd. 6.Director. (a) The governor shall appoint a director of the office with the advice 
37.4 	and consent of the senate. The director must be in the unclassified service and must serve 
37.5 	at the pleasure of the governor.
37.6 	(b) The salary of the director must not exceed the salary limit established under section 
37.7 	15A.0815, subdivision 3.
37.8 	(b) The director may appoint and employ no more than two deputy directors.
37.9 	(c) The director has administrative control of the office. The director has the powers 
37.10 	described in section 15.06, subdivision 6.
37.11 	(d) The director may apply for and accept on behalf of the state any grants, bequests, 
37.12 	gifts, or contributions for the purpose of carrying out the duties and responsibilities of the 
37.13 	director.
37.14 	(e) Pursuant to state law, the director may apply for and receive money made available 
37.15 	from federal sources for the purpose of carrying out the duties and responsibilities of the 
37.16 	director.
37.17 	(f) The director may make contracts with and grants to Tribal Nations, public and private 
37.18 	agencies, for-profit and nonprofit organizations, and individuals using appropriated money.

37.19 	Sec. 47. Minnesota Statutes 2023 Supplement, section 342.03, subdivision 1, is amended 
37.20 	to read:
37.21 		Subdivision 1.Membership. The Cannabis Advisory Council is created consisting of 
37.22 	the following members:
37.23 	(1) the director of the Office of Cannabis Management or a designee;
37.24 	(2) the commissioner of employment and economic development or a designee;
37.25 	(3) the commissioner of revenue or a designee;
37.26 	(4) the commissioner of health or a designee;
37.27 	(5) the commissioner of human services or a designee;
37.28 	(6) the commissioner of public safety or a designee;
37.29 	(7) the commissioner of human rights or a designee;
37.30 	(8) the commissioner of labor or a designee;
38.1 	(9) the commissioner of agriculture or a designee;
38.2 	(10) the commissioner of the Pollution Control Agency or a designee;
38.3 	(11) the superintendent of the Bureau of Criminal Apprehension or a designee;
38.4 	(12) the colonel of the State Patrol or a designee;
38.5 	(13) the director of the Office of Traffic Safety in the Department of Public Safety or a 
38.6 	designee;
38.7 	(14) a representative from the League of Minnesota Cities appointed by the league;
38.8 	(15) a representative from the Association of Minnesota Counties appointed by the 
38.9 	association;
38.10 	(16) an expert in minority business development appointed by the governor;
38.11 	(17) an expert in economic development strategies for under-resourced communities 
38.12 	appointed by the governor;
38.13 	(18) an expert in farming or representing the interests of farmers appointed by the 
38.14 	governor;
38.15 	(19) an expert representing the interests of cannabis workers appointed by the governor;
38.16 	(20) an expert representing the interests of employers appointed by the governor;
38.17 	(21) an expert in municipal law enforcement with advanced training in impairment 
38.18 	detection and evaluation appointed by the governor;
38.19 	(22) an expert in social welfare or social justice appointed by the governor;
38.20 	(23) an expert in criminal justice reform to mitigate the disproportionate impact of drug 
38.21 	prosecutions on communities of color appointed by the governor;
38.22 	(24) an expert in prevention, treatment, and recovery related to substance use disorders 
38.23 	appointed by the governor;
38.24 	(25) an expert in minority business ownership appointed by the governor;
38.25 	(26) an expert in women-owned businesses appointed by the governor;
38.26 	(27) an expert in cannabis retailing appointed by the governor;
38.27 	(28) an expert in cannabis product manufacturing appointed by the governor;
38.28 	(29) an expert in laboratory sciences and toxicology appointed by the governor;
39.1 	(30) an expert in providing legal services to cannabis businesses appointed by the 
39.2 	governor;
39.3 	(31) an expert in cannabis cultivation appointed by the governor;
39.4 	(32) an expert in pediatric medicine appointed by the governor;
39.5 	(33) an expert in adult medicine appointed by the governor;
39.6 	(34) an expert in clinical pharmacy appointed by the governor;
39.7 	(35) three patient advocates, one who is a patient enrolled in the medical cannabis 
39.8 	program; one who is a parent or caregiver of a patient in the medical cannabis program; 
39.9 	and one patient with experience in the mental health system or substance use disorder 
39.10 	treatment system appointed by the governor;
39.11 	(35) (36) two licensed mental health professionals appointed by the governor;
39.12 	(36) (37) a veteran appointed by the governor;
39.13 	(37) (38) one member of each of the following federally recognized Tribes, designated 
39.14 	by the elected Tribal president or chairperson of the governing bodies of:
39.15 	(i) the Fond du Lac Band;
39.16 	(ii) the Grand Portage Band;
39.17 	(iii) the Mille Lacs Band;
39.18 	(iv) the White Earth Band;
39.19 	(v) the Bois Forte Band;
39.20 	(vi) the Leech Lake Band;
39.21 	(vii) the Red Lake Nation;
39.22 	(viii) the Upper Sioux Community;
39.23 	(ix) the Lower Sioux Indian Community;
39.24 	(x) the Shakopee Mdewakanton Sioux Community; and
39.25 	(xi) the Prairie Island Indian Community; and
39.26 	(38) (39) a representative from the Local Public Health Association of Minnesota 
39.27 	appointed by the association.

40.1 	Sec. 48. Minnesota Statutes 2023 Supplement, section 342.03, subdivision 4, is amended 
40.2 	to read:
40.3 		Subd. 4.Duties. (a) The duties of the advisory council shall include:
40.4 	(1) reviewing national cannabis policy;
40.5 	(2) examining the effectiveness of state cannabis policy;
40.6 	(3) reviewing developments in the cannabis industry and hemp consumer industry;
40.7 	(4) reviewing developments in the study of cannabis flower, cannabis products, artificially 
40.8 	derived cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products;
40.9 	(5) taking public testimony; and
40.10 	(6) studying the impact of legalized adult-use cannabis on the rate of cannabis use by 
40.11 	minors; and
40.12 	(6) (7) making recommendations to the Office of Cannabis Management.
40.13 	(b) At its discretion, the advisory council may examine other related issues consistent 
40.14 	with this section.

40.15 	Sec. 49. Minnesota Statutes 2023 Supplement, section 342.06, is amended to read:
40.16 	342.06 APPROVAL OF CANNABIS FLOWER, PRODUCTS, AND 
40.17 	CANNABINOIDS.
40.18 		Subdivision 1.Approval of cannabis flower and products. (a) For the purposes of 
40.19 	this section, "product category" means a type of product that may be sold in different sizes, 
40.20 	distinct packaging, or at various prices but is still created using the same manufacturing or 
40.21 	agricultural processes. A new or additional stock keeping unit (SKU) or Universal Product 
40.22 	Code (UPC) shall not prevent a product from being considered the same type as another 
40.23 	unit. All other terms have the meanings provided in section 342.01.
40.24 	(b) The office shall approve product categories of cannabis flower, cannabis products, 
40.25 	lower-potency hemp edibles, and hemp-derived consumer products for retail sale.
40.26 	(c) The office may establish limits on the total THC of cannabis flower, cannabis products, 
40.27 	and hemp-derived consumer products. As used in this paragraph, "total THC" means the 
40.28 	sum of the percentage by weight of tetrahydrocannabinolic acid multiplied by 0.877 plus 
40.29 	the percentage by weight of all tetrahydrocannabinols.
40.30 	(d) The office shall not approve any cannabis product, lower-potency hemp edible, or 
40.31 	hemp-derived consumer product that:
41.1 	(1) is or appears to be a lollipop or ice cream;
41.2 	(2) bears the likeness or contains characteristics of a real or fictional person, animal, or 
41.3 	fruit;
41.4 	(3) is modeled after a type or brand of products primarily consumed by or marketed to 
41.5 	children;
41.6 	(4) is substantively similar to a meat food product; poultry food product as defined in 
41.7 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
41.8 	7;
41.9 	(5) contains a synthetic cannabinoid;
41.10 	(6) is made by applying a cannabinoid, including but not limited to an artificially derived 
41.11 	cannabinoid, to a finished food product that does not contain cannabinoids and is sold to 
41.12 	consumers, including but not limited to a candy or snack food; or
41.13 	(7) if the product is an edible cannabis product or lower-potency hemp edible, contains 
41.14 	an ingredient, other than a cannabinoid, that is not approved by the United States Food and 
41.15 	Drug Administration for use in food.
41.16 		Subd. 2.Approval of cannabinoids. (a) The office may designate any cannabinoid as 
41.17 	nonintoxicating and may approve the use of any cannabinoid in lower-potency hemp edibles. 
41.18 	The office may establish limits on the amount of an intoxicating cannabinoid that may be 
41.19 	present in a lower-potency hemp edible.
41.20 	(b) Beginning January 1, 2026, any person may petition the office to designate a 
41.21 	cannabinoid as nonintoxicating or to allow the use of any cannabinoid in lower-potency 
41.22 	hemp edibles. Petitions must be filed in the form and manner established by the office and 
41.23 	must:
41.24 	(1) specify the cannabinoid that is the subject of the petition;
41.25 	(2) indicate whether the petition seeks to have the cannabinoid designated as 
41.26 	nonintoxicating or approved for use in lower-potency hemp edibles;
41.27 	(3) indicate whether the cannabinoid has been identified in cannabis plants, cannabis 
41.28 	extract, hemp plant parts, or hemp extract; and
41.29 	(4) include verified data, validated studies, or other evidence that is generally relied 
41.30 	upon in the scientific community to support the petition.
41.31 	(c) The office must post all final determinations on the office's publicly facing website.
42.1 	(d) If the office denies a petition to designate a cannabinoid as nonintoxicating or to 
42.2 	allow the cannabinoid's use in lower-potency hemp edibles, that denial shall be in effect for 
42.3 	two years. Any petition filed under this subdivision within two years of a final determination 
42.4 	denying a petition for the same cannabinoid must be summarily denied.

42.5 	Sec. 50. Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended 
42.6 	to read:
42.7 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person seeking 
42.8 	to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency 
42.9 	hemp edible, other than an edible cannabis product or lower-potency hemp edible that has 
42.10 	been placed in its final packaging, must first obtain an edible cannabinoid product handler 
42.11 	endorsement.
42.12 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
42.13 	edible cannabinoid product handler endorsement.
42.14 	(c) The office must regulate edible cannabinoid product handlers and assess penalties 
42.15 	in the same in a manner provided for consistent with Department of Agriculture regulation 
42.16 	of food handlers under chapters 28A, 31, and 34A and associated rules, with the following 
42.17 	exceptions:
42.18 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
42.19 	a license;
42.20 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
42.21 	who possess a valid license issued by the office;
42.22 	(3) the office may not charge a fee for issuing or renewing the endorsement;
42.23 	(4) the office must align the term and renewal period for edible cannabinoid product 
42.24 	handler endorsements with the term and renewal period of the license issued by the office; 
42.25 	and
42.26 	(5) an edible cannabis product or lower-potency hemp edible must not be considered 
42.27 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
42.28 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
42.29 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
42.30 	parts.
42.31 	(d) The edible cannabinoid product handler endorsement must prohibit the manufacture 
42.32 	of edible cannabis products at the same premises where food is manufactured, except for 
43.1 	the limited production of edible products produced solely for product development, sampling, 
43.2 	or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

43.3 	Sec. 51. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended 
43.4 	to read:
43.5 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
43.6 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
43.7 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
43.8 	manufacturer, medical cannabis processor combination business, or lower-potency hemp 
43.9 	edible manufacturer license issued under this chapter.

43.10 	Sec. 52. Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:
43.11 	342.10 LICENSES; TYPES.
43.12 	The office shall issue the following types of license:
43.13 	(1) cannabis microbusiness;
43.14 	(2) cannabis mezzobusiness;
43.15 	(3) cannabis cultivator;
43.16 	(4) cannabis manufacturer;
43.17 	(5) cannabis retailer;
43.18 	(6) cannabis wholesaler;
43.19 	(7) cannabis transporter;
43.20 	(8) cannabis testing facility;
43.21 	(9) cannabis event organizer;
43.22 	(10) cannabis delivery service;
43.23 	(11) lower-potency hemp edible manufacturer;
43.24 	(12) lower-potency hemp edible retailer; and
43.25 	(13) medical cannabis cultivator;
43.26 	(14) medical cannabis processor;
43.27 	(15) medical cannabis retailer; or
43.28 	(16) (13) medical cannabis combination business.

44.1 	Sec. 53. Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:
44.2 	342.11 LICENSES; FEES.
44.3 	(a) The office shall require the payment of application fees, initial licensing fees, and 
44.4 	renewal licensing fees as provided in this section. The initial license fee shall include the 
44.5 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
44.6 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
44.7 	Nothing in this section prohibits a local unit of government from charging the retailer 
44.8 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
44.9 	renewal licensing fees are nonrefundable.
44.10 	(b) Application and licensing fees shall be as follows:
44.11 	(1) for a cannabis microbusiness:
44.12 	(i) an application fee of $500;
44.13 	(ii) an initial license fee of $0; and
44.14 	(iii) a renewal license fee of $2,000;
44.15 	(2) for a cannabis mezzobusiness:
44.16 	(i) an application fee of $5,000;
44.17 	(ii) an initial license fee of $5,000; and
44.18 	(iii) a renewal license fee of $10,000;
44.19 	(3) for a cannabis cultivator:
44.20 	(i) an application fee of $10,000;
44.21 	(ii) an initial license fee of $20,000; and
44.22 	(iii) a renewal license fee of $30,000;
44.23 	(4) for a cannabis manufacturer:
44.24 	(i) an application fee of $10,000;
44.25 	(ii) an initial license fee of $10,000; and
44.26 	(iii) a renewal license fee of $20,000;
44.27 	(5) for a cannabis retailer:
44.28 	(i) an application fee of $2,500;
44.29 	(ii) an initial license fee of $2,500; and
45.1 	(iii) a renewal license fee of $5,000;
45.2 	(6) for a cannabis wholesaler:
45.3 	(i) an application fee of $5,000;
45.4 	(ii) an initial license fee of $5,000; and
45.5 	(iii) a renewal license fee of $10,000;
45.6 	(7) for a cannabis transporter:
45.7 	(i) an application fee of $250;
45.8 	(ii) an initial license fee of $500; and
45.9 	(iii) a renewal license fee of $1,000;
45.10 	(8) for a cannabis testing facility:
45.11 	(i) an application fee of $5,000;
45.12 	(ii) an initial license fee of $5,000; and
45.13 	(iii) a renewal license fee of $10,000;
45.14 	(9) for a cannabis delivery service:
45.15 	(i) an application fee of $250;
45.16 	(ii) an initial license fee of $500; and
45.17 	(iii) a renewal license fee of $1,000;
45.18 	(10) for a cannabis event organizer:
45.19 	(i) an application fee of $750; and
45.20 	(ii) an initial license fee of $750;
45.21 	(11) for a lower-potency hemp edible manufacturer:
45.22 	(i) an application fee of $250;
45.23 	(ii) an initial license fee of $1,000; and
45.24 	(iii) a renewal license fee of $1,000;
45.25 	(12) for a lower-potency hemp edible retailer:
45.26 	(i) an application fee of $250 per retail location;
45.27 	(ii) an initial license fee of $250 per retail location; and
46.1 	(iii) a renewal license fee of $250 per retail location; and
46.2 	(13) for a medical cannabis cultivator:
46.3 	(i) an application fee of $250;
46.4 	(ii) an initial license fee of $0; and
46.5 	(iii) a renewal license fee of $0;
46.6 	(14) for a medical cannabis processor:
46.7 	(i) an application fee of $250;
46.8 	(ii) an initial license fee of $0; and
46.9 	(iii) a renewal license fee of $0;
46.10 	(15) for a medical cannabis retailer:
46.11 	(i) an application fee of $250;
46.12 	(ii) an initial license fee of $0; and
46.13 	(iii) a renewal license fee of $0; and
46.14 	(16) (13) for a medical cannabis combination business:
46.15 	(i) an application fee of $10,000;
46.16 	(ii) an initial license fee of $20,000; and
46.17 	(iii) a renewal license fee of $70,000.

46.18 	Sec. 54. Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:
46.19 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
46.20 	(a) Licenses issued under this chapter that are available to all applicants pursuant to 
46.21 	section 342.18, subdivision 4, paragraph (g), may be freely transferred subject to the prior 
46.22 	written approval of the office, which approval may be given or withheld in the office's sole 
46.23 	discretion, provided that a social equity applicant may only transfer the applicant's license 
46.24 	to another social equity applicant.
46.25 	(b) Licenses issued as social equity licenses pursuant to either section 342.18, subdivision 
46.26 	4, paragraph (f), or section 342.175, paragraph (b), may only be transferred to another social 
46.27 	equity applicant for three years after the date on which the office issues the license. Three 
46.28 	years after the date of issuance, a license holder may transfer a license to any entity. Transfer 
47.1 	of a license that was issued as a social equity license must be reviewed by the Division of 
47.2 	Social Equity and is subject to the prior written approval of the office.
47.3 	(c) License preapproval issued pursuant to section 342.125 may not be transferred.
47.4 	(d) A new license must be obtained when:
47.5 	(1) the form of the licensee's legal business structure converts or changes to a different 
47.6 	type of legal business structure; or
47.7 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
47.8 	or receivership proceedings; merges with another legal organization; or assigns all or 
47.9 	substantially all of its assets for the benefit of creditors.
47.10 	(b) Transfers between social equity applicants must be reviewed by the Division of 
47.11 	Social Equity.
47.12 	(c) (e) Licenses must be renewed annually.
47.13 	(d) (f) License holders may petition the office to adjust the tier of a license issued within 
47.14 	a license category provided that if the license holder meets all applicable requirements.
47.15 	(e) (g) The office by rule may permit the relocation of a licensed cannabis business,; 
47.16 	permit the relocation of an approved operational location, including a cultivation, 
47.17 	manufacturing, processing, or retail location; adopt requirements for the submission of a 
47.18 	license relocation application,; establish standards for the approval of a relocation 
47.19 	application,; and charge a fee not to exceed $250 for reviewing and processing applications. 
47.20 	Relocation of a licensed premises pursuant to this paragraph does not extend or otherwise 
47.21 	modify the license term of the license subject to relocation.

47.22 	Sec. 55. [342.125] LICENSE PREAPPROVAL.
47.23 		Subdivision 1.Preapproval. (a) The office may establish a license preapproval process 
47.24 	for applicants who meet the requirements in section 342.17.
47.25 	(b) The office may issue up to the following number of license preapprovals:
47.26 	(1) cannabis microbusiness licenses, 100;
47.27 	(2) cannabis mezzobusiness licenses, 25;
47.28 	(3) cannabis cultivator licenses, 13;
47.29 	(4) cannabis manufacturer licenses, six;
47.30 	(5) cannabis retailer licenses, 50;
48.1 	(6) cannabis wholesaler licenses, 20;
48.2 	(7) cannabis transporter licenses, 20;
48.3 	(8) cannabis testing facility licenses, 50; and
48.4 	(9) cannabis delivery service licenses, ten.
48.5 	(c) License preapproval remains valid for 18 months from the date that the office adopts 
48.6 	initial rules pursuant to section 342.02, subdivision 5, unless the office revokes the 
48.7 	preapproval. If a person has not converted a preapproval into a license within 18 months, 
48.8 	the preapproval expires.
48.9 	(d) By August 15, 2024, the office must announce the commencement of an initial 
48.10 	application period for license preapproval. By October 1, 2024, the office must issue license 
48.11 	preapprovals to eligible applicants who submit an application in the initial application period. 
48.12 	The office must prioritize license categories that authorize the cultivation of cannabis plants. 
48.13 	At a minimum, the office must make the following number of licenses available for 
48.14 	preapproval in the initial application period:
48.15 	(1) cannabis microbusiness licenses, 100;
48.16 	(2) cannabis mezzobusiness licenses, 25;
48.17 	(3) cannabis cultivator licenses, 26; and
48.18 	(4) cannabis testing facility licenses, 50.
48.19 		Subd. 2.Eligibility. (a) Only a social equity applicant who meets the requirements in 
48.20 	section 342.17 is eligible for license preapproval.
48.21 	(b) The office must not issue a license preapproval if the applicant would be prohibited 
48.22 	from holding the license under section 342.18, subdivision 2.
48.23 		Subd. 3.Application; contents. (a) An applicant for preapproval must:
48.24 	(1) complete an application that contains the information described in section 342.14, 
48.25 	subdivision 1, on a form approved by the office; and
48.26 	(2) pay the applicable application fee required under section 342.11, paragraph (b), for 
48.27 	the license being sought.
48.28 	(b) The office shall not require an applicant to possess or identify any property on which 
48.29 	the cannabis business will operate.
49.1 		Subd. 4.Application process. (a) The office must announce the commencement of an 
49.2 	application period for license preapproval at least 14 days before the date that the office 
49.3 	begins to accept applications. The announcement must include:
49.4 	(1) the types of licenses that will be available for preapproval during the application 
49.5 	period;
49.6 	(2) the number of each type of license available;
49.7 	(3) the date on which the application period will begin; and
49.8 	(4) the date on which the application period will end.
49.9 	(b) The office must accept applications for license preapproval for 30 calendar days 
49.10 	during an application period.
49.11 	(c) Before proceeding with a review of the application, the office must verify the 
49.12 	applicant's status as a social equity applicant.
49.13 	(d) The office may deny an application for preapproval that:
49.14 	(1) is incomplete;
49.15 	(2) contains a material false statement about the applicant or omits material information 
49.16 	about the applicant;
49.17 	(3) is from an applicant that does not meet the requirements in section 342.17;
49.18 	(4) fails to meet the minimum qualifications for the license in section 342.18, subdivision 
49.19 	3;
49.20 	(5) is from an applicant who fails to pay the applicable application fee; or
49.21 	(6) is not submitted by the deadline established by the office.
49.22 	(e) If the office denies an application for preapproval, the office must notify the applicant 
49.23 	of the denial and the basis for the denial.
49.24 	(f) The office may request additional information from any applicant if the office 
49.25 	determines that the information is necessary to review or process the application. If the 
49.26 	applicant does not provide the additional requested information within 14 calendar days of 
49.27 	the office's request for information, the office may deny the application.
49.28 		Subd. 5.Issuance of preapproval; lottery. (a) An applicant who meets the requirements 
49.29 	in subdivisions 2, 3, and 4 is a qualified applicant and the office may issue a license 
49.30 	preapproval to the applicant.
50.1 	(b) If there are fewer license preapprovals available than the number of qualified 
50.2 	applicants for that license type, the office must conduct a lottery to select applicants for 
50.3 	preapproval. The lottery must include all qualified applicants seeking preapproval for the 
50.4 	license type and must be impartial, random, and in a format determined by the office.
50.5 	(c) The office may remove an applicant from the lottery if the office determines that:
50.6 	(1) the applicant has violated an ownership or operational requirement in this chapter 
50.7 	or rules adopted pursuant to this chapter that would justify revocation or nonrenewal of a 
50.8 	license;
50.9 	(2) the applicant is disqualified from holding a license pursuant to section 342.15; or
50.10 	(3) the applicant is determined to be in arrears on property, business, or personal taxes.
50.11 	(d) If the office removes an applicant from a lottery, the office must notify the applicant 
50.12 	of the removal and the basis for the removal. If an applicant is not selected in a lottery, the 
50.13 	office must notify the applicant that the applicant was not selected.
50.14 		Subd. 6.License preapproval; purpose; restrictions. (a) License preapproval issued 
50.15 	by the office is evidence that the applicant has submitted all necessary information to the 
50.16 	office; the office has determined that the applicant is qualified to hold a license of the type 
50.17 	that is preapproved; and the office will issue the person a license after the office adopts 
50.18 	initial rules pursuant to section 342.02, subdivision 5, unless the office revokes preapproval 
50.19 	pursuant to subdivision 7.
50.20 	(b) Upon request by a person who has been preapproved for a license, the office must 
50.21 	provide confirmation of the preapproval to third parties to assist the person in taking the 
50.22 	steps necessary to prepare for business operations, including:
50.23 	(1) establishing legal control of the site of the cannabis business through lease, purchase, 
50.24 	or other means;
50.25 	(2) gaining zoning or planning approval for the site of the cannabis business from a local 
50.26 	unit of government; and
50.27 	(3) raising capital for the person's business operations.
50.28 	(c) License preapproval does not authorize a person to open a cannabis business or 
50.29 	engage in any activity that requires a license issued under this chapter.
50.30 	(d) A person with a license preapproval shall not:
51.1 	(1) purchase, possess, cultivate, manufacture, distribute, dispense, or sell cannabis plants, 
51.2 	cannabis flower, cannabis products, medical cannabis flower, or medical cannabinoid 
51.3 	products;
51.4 	(2) manufacture, distribute, or sell edible cannabinoid products or lower-potency hemp 
51.5 	edibles unless the person has explicit permission to engage in those activities from the office 
51.6 	and has a valid license authorizing those actions or is registered pursuant to section 151.72;
51.7 	(3) make any transfer of an ownership interest that causes a change in the individual or 
51.8 	entity that holds the controlling ownership interest;
51.9 	(4) make any change or transfer of ownership or control that would require a new business 
51.10 	registration with the secretary of state; or
51.11 	(5) make any transfer of ownership interest that causes the person with a license 
51.12 	preapproval to no longer qualify as a social equity applicant under section 342.17.
51.13 		Subd. 7.Revocation of preapproval. The office may revoke a license preapproval if 
51.14 	the individual holding the preapproval or, if preapproval is granted to a business entity, any 
51.15 	cooperative member or director, manager, or general partner of the business entity:
51.16 	(1) fraudulently or deceptively obtained preapproval;
51.17 	(2) fails to reveal any material fact pertaining to the qualification for preapproval;
51.18 	(3) violates any provision of this chapter;
51.19 	(4) is not registered or in good standing with the Office of the Secretary of State; or
51.20 	(5) is in arrears on property, business, or personal taxes.
51.21 		Subd. 8.Conversion of preapproval. (a) The office must grant a license to any person 
51.22 	who has received a license preapproval after the office:
51.23 	(1) adopts initial rules pursuant to section 342.02, subdivision 5; and
51.24 	(2) receives the applicable license fee pursuant to section 342.11.
51.25 	(b) The office must not grant a license to a person who has received a license preapproval 
51.26 	if:
51.27 	(1) the ownership of the business has changed since the office granted a license 
51.28 	preapproval and the person has not filed an updated ownership disclosure as required by 
51.29 	section 342.14, subdivision 1, paragraph (b); or
51.30 	(2) the cannabis business for which the office granted a license preapproval does not 
51.31 	meet local zoning and land use laws.
52.1 		Subd. 9.Applicants; right to a reconsideration. (a) If the office denies an application 
52.2 	for a license preapproval or removes an application from a lottery, the applicant may request 
52.3 	a records review of the submitted application materials within seven calendar days of 
52.4 	receiving notification that the office denied or removed the application.
52.5 	(b) Upon an applicant's request, the office must allow the applicant to examine the 
52.6 	applicant's records received by the office.
52.7 	(c) A person whose license preapproval is later revoked by the office may request 
52.8 	reconsideration by the director.
52.9 	(d) A person whose application is denied, removed from a lottery, or not selected in a 
52.10 	lottery may not appeal or request a hearing.
52.11 		Subd. 10.Retention of applications. (a) A qualified applicant whose application is not 
52.12 	selected for a license preapproval in a lottery may request that the office retain the application 
52.13 	for subsequent application periods.
52.14 	(b) If a qualified applicant requests that the office retain an application, the office must 
52.15 	retain the application for one year after the date of the request.
52.16 	(c) The office may request additional information from any applicant whose application 
52.17 	is retained if the office determines that the information is necessary to determine if the 
52.18 	applicant meets the requirements for a subsequent application period. If the applicant does 
52.19 	not provide the additional requested information within 14 calendar days of the office's 
52.20 	request for information, the office may deny the application.
52.21 	(d) The office may disqualify an application from retention under the grounds specified 
52.22 	in subdivision 5, paragraph (c).
52.23 	(e) If the office announces an application period, any application retained by the office 
52.24 	may be granted a license preapproval or be entered in a lottery if the applicant amends an 
52.25 	application or provides additional information at the request of the office. The office must 
52.26 	not charge an additional application fee before granting license preapproval to an applicant 
52.27 	whose application was retained by the office or entering an application retained by the office 
52.28 	in a lottery.

53.1 	Sec. 56. Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:
53.2 	342.13 LOCAL CONTROL.
53.3 	(a) A local unit of government may not prohibit the possession, transportation, or use 
53.4 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
53.5 	consumer products authorized under this chapter.
53.6 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
53.7 	the establishment or operation of a cannabis business or hemp business licensed under this 
53.8 	chapter.
53.9 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
53.10 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
53.11 	the establishment or operation of cannabis businesses. A local unit of government may 
53.12 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
53.13 	day care, residential treatment facility, or an attraction within a public park that is regularly 
53.14 	used by minors, including a playground or athletic field.
53.15 	(d) The office shall work with local units of government to:
53.16 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
53.17 	of the operation of a cannabis business;
53.18 	(2) develop standardized forms and procedures for the issuance of a retail registration 
53.19 	pursuant to section 342.22; and
53.20 	(3) develop model policies and procedures for the performance of compliance checks 
53.21 	required under section 342.22.
53.22 	(e) If a local unit of government is conducting studies or has authorized a study to be 
53.23 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
53.24 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
53.25 	a cannabis business, the governing body of the local unit of government may adopt an 
53.26 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
53.27 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
53.28 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
53.29 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
53.30 	or a portion thereof until January 1, 2025.
53.31 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
53.32 	government shall certify on a form provided by the office whether a proposed cannabis 
53.33 	business complies with local zoning ordinances and, if applicable, whether the proposed 
54.1 	business complies with the state fire code and building code. The office may not issue a 
54.2 	licensean endorsement to a cannabis business if a the cannabis business does not meet local 
54.3 	zoning and land use laws.
54.4 	(g) Upon receipt of an application for a license issued under this chapter, the office shall 
54.5 	contact the local unit of government in which the business would be located and provide 
54.6 	the local unit of government with 30 days in which to provide input on the application. The 
54.7 	local unit of government may provide the office with any additional information it believes 
54.8 	is relevant to the office's decision on whether to issue a license, including but not limited 
54.9 	to identifying concerns about the proposed location of a cannabis business or sharing public 
54.10 	information about an applicant.
54.11 	(h) (g) The office by rule shall establish an expedited complaint process to receive, 
54.12 	review, and respond to complaints made by a local unit of government about a cannabis 
54.13 	business. Complaints may include alleged violations of local ordinances or other alleged 
54.14 	violations. The office may only investigate complaints alleging a violation of this chapter.
54.15 	At a minimum, the expedited complaint process shall require the office to provide an initial 
54.16 	response to the complaint within seven days and perform any necessary inspections within 
54.17 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
54.18 	local ordinance. If a local unit of government notifies the office that a cannabis business 
54.19 	other than a cannabis retailer, cannabis microbusiness or cannabis mezzobusiness with a 
54.20 	retail operations endorsement, cannabis mezzobusiness, lower-potency hemp edible retailer, 
54.21 	medical cannabis retailer, or medical cannabis combination business operating a retail 
54.22 	location poses an immediate threat to the health or safety of the public, the office must 
54.23 	respond within one business day and may take any action described in section 342.19 or 
54.24 	342.21.
54.25 	(i) (h) A local government unit that issues a cannabis retailer registration under section 
54.26 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
54.27 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
54.28 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
54.29 	(j) (i) If a county has one active registration for every 12,500 residents, a city or town 
54.30 	within the county is not obligated to register a cannabis business.
54.31 	(k) (j) Nothing in this section shall prohibit a local government unit from allowing 
54.32 	licensed cannabis retailers in excess of the minimums set in paragraph (i) (h).
54.33 	(l) (k) Notwithstanding the foregoing provisions, the state shall not issue a license to 
54.34 	any cannabis business to operate in Indian country, as defined in United States Code, title 
55.1 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
55.2 	government.

55.3 	Sec. 57. Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:
55.4 	342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.
55.5 		Subdivision 1.Application; contents. (a) The office by rule shall establish forms and 
55.6 	procedures for the processing of cannabis business licenses issued under this chapter. At a 
55.7 	minimum, any application to obtain or renew a cannabis license shall The office must direct 
55.8 	an applicant to include the following information, if applicable in an application to obtain 
55.9 	or renew a cannabis license:
55.10 	(1) the name, address, and date of birth of the applicant;
55.11 	(2) the disclosure of ownership and control required under paragraph (b);
55.12 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
55.13 	director, manager, and general partner of the business has ever filed for bankruptcy;
55.14 	(4) the address and legal property description of the business, if applicable, except an 
55.15 	applicant is not required to secure a physical premises for the business at the time of 
55.16 	application;
55.17 	(5) a general description of the location or locations that the applicant plans to operate, 
55.18 	including the planned square feet of planned space for cultivation, wholesaling, and retailing, 
55.19 	as applicable;
55.20 	(6) a copy of the security plan;
55.21 	(7) proof of trade name registration;
55.22 	(8) a copy of the applicant's business plan showing the expected size of the business; 
55.23 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
55.24 	applicant and any officer, director, manager, and general partner of the business; the 
55.25 	environmental plan; and other relevant financial and operational components;
55.26 	(9) an attestation signed by a bona fide labor organization stating that the applicant has 
55.27 	entered into a labor peace agreement;
55.28 	(10) certification that the applicant will comply with the requirements of this chapter 
55.29 	relating to the ownership and operation of a cannabis business;
55.30 	(11) identification of one or more controlling persons or managerial employees as agents 
55.31 	who shall be responsible for dealing with the office on all matters; and
56.1 	(12) a statement that the applicant agrees to respond to the office's supplemental requests 
56.2 	for information.
56.3 	(b) An applicant must file and update as necessary a disclosure of ownership and control. 
56.4 	The office by rule shall establish the contents and form of the disclosure. Except as provided 
56.5 	in paragraph (f), the disclosure shall, at a minimum, include the following:
56.6 	(1) the management structure, ownership, and control of the applicant or license holder, 
56.7 	including the name of each cooperative member, officer, director, manager, general partner, 
56.8 	or business entity; the office or position held by each person; each person's percentage 
56.9 	ownership interest, if any; and, if the business has a parent company, the name of each 
56.10 	owner, board member, and officer of the parent company and the owner's, board member's, 
56.11 	or officer's percentage ownership interest in the parent company and the cannabis business;
56.12 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
56.13 	director, manager, and general partner of the business, indicating whether that person has 
56.14 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
56.15 	any other state or territory of the United States, or any other country;
56.16 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
56.17 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
56.18 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
56.19 	(5) copies of any promissory notes, security instruments, or other similar agreements;
56.20 	(6) an explanation detailing the funding sources used to finance the business;
56.21 	(7) a list of operating and investment accounts for the business, including any applicable 
56.22 	financial institution and account number; and
56.23 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
56.24 	including the loan amount, loan terms, and name and address of the creditor.
56.25 	(c) An application may include:
56.26 	(1) proof that the applicant is a social equity applicant;
56.27 	(2) a description of the training and education that will be provided to any employee; 
56.28 	or
56.29 	(3) a copy of business policies governing operations to ensure compliance with this 
56.30 	chapter.
57.1 	(d) Commitments made by an applicant in its application, including but not limited to 
57.2 	the maintenance of a labor peace agreement, shall be an ongoing material condition of 
57.3 	maintaining and renewing the license.
57.4 	(e) An application on behalf of a corporation or association shall be signed by at least 
57.5 	two officers or managing agents of that entity.
57.6 	(f) The office may, by rule, establish exceptions to the disclosures required under 
57.7 	paragraph (b) for members of a cooperative who hold less than a five percent ownership 
57.8 	interest in the cooperative.
57.9 		Subd. 2.Application; process. (a) An applicant must submit all required information 
57.10 	to the office on the forms and in the manner prescribed by the office.
57.11 	(b) If the office receives an application that fails to provide the required information, 
57.12 	the office shall issue a deficiency notice to the applicant. The applicant shall have ten 
57.13 	business days from the date of the deficiency notice to submit the required information.
57.14 	(c) Failure by an applicant to submit all required information will result in the application 
57.15 	being rejected.
57.16 	(d) Upon receipt of a completed application and fee, the office shall forward a copy of 
57.17 	the application to the local unit of government in which the business operates or intends to 
57.18 	operate with a form for certification as to whether a proposed cannabis business complies 
57.19 	with local zoning ordinances and, if applicable, whether the proposed business complies 
57.20 	with the state fire code and building code.
57.21 	(e) (d) Within 90 days of receiving a completed application and the results of any required 
57.22 	criminal history check, the office shall issue the appropriate license or send the applicant a 
57.23 	notice of rejection setting forth specific reasons that the office did not approve the application.
57.24 		Subd. 3.License revocation. The office may revoke a cannabis business license if the 
57.25 	licensee has not made good faith efforts to obtain an endorsement within 18 months of the 
57.26 	date that the license was issued.

57.27 	Sec. 58. Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a 
57.28 	subdivision to read:
57.29 		Subd. 5.Civil and regulatory offenses; disqualifications. The office may determine 
57.30 	whether any civil or regulatory violations, as determined by another state agency, local unit 
57.31 	of government, or any other jurisdiction, disqualify an individual from holding or receiving 
57.32 	a cannabis business license issued under this chapter or disqualify an individual from working 
58.1 	for a cannabis business and the length of the disqualification. For purposes of making a 
58.2 	determination under this subdivision, and notwithstanding the data's classification under 
58.3 	chapter 13, the office may access civil investigatory data about an applicant maintained by 
58.4 	any other government entity.

58.5 	Sec. 59. [342.151] EMPLOYEES OF LICENSE HOLDERS.
58.6 		Subdivision 1.Definitions. For purposes of this section, a "license holder" includes a 
58.7 	cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, 
58.8 	cannabis retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis 
58.9 	event organizer, cannabis delivery service, lower-potency hemp edible manufacturer, 
58.10 	lower-potency hemp edible retailer, or medical cannabis combination business.
58.11 		Subd. 2.Disqualification. (a) A license holder must not employ an individual as a 
58.12 	cannabis worker if the individual has been convicted of any of the following crimes that 
58.13 	would constitute a felony:
58.14 	(1) human trafficking;
58.15 	(2) noncannabis controlled substance crimes in the first or second degree;
58.16 	(3) labor trafficking;
58.17 	(4) fraud;
58.18 	(5) embezzlement;
58.19 	(6) extortion;
58.20 	(7) money laundering; or
58.21 	(8) insider trading;
58.22 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
58.23 	has not been granted.
58.24 	(b) A license holder must not employ an individual as a cannabis worker if the individual 
58.25 	made any false statement in an application for employment.

58.26 	Sec. 60. Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:
58.27 	342.17 SOCIAL EQUITY APPLICANTS.
58.28 	(a) An applicant qualifies as a social equity applicant if the applicant:
59.1 	(1) was convicted of an offense involving the possession or sale of cannabis or marijuana 
59.2 	prior to May 1, 2023;
59.3 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
59.4 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
59.5 	(3) was a dependent of an individual who was convicted of an offense involving the 
59.6 	possession or sale of cannabis or marijuana prior to May 1, 2023;
59.7 	(4) is a military veteran, including status as a service-disabled veteran, current or former 
59.8 	member of the national guard, or any military veteran or current or former member of the 
59.9 	national guard who lost honorable status due to an offense involving the possession or sale 
59.10 	of cannabis or marijuana;
59.11 	(5) has been a resident for the last five years of one or more subareas, such as census 
59.12 	tracts or neighborhoods, that experienced a disproportionately large amount of cannabis 
59.13 	enforcement as determined by the study conducted by the office pursuant to section 342.04, 
59.14 	paragraph (b), and reported in the preliminary report, final report, or both;
59.15 	(6) is an emerging farmer as defined in section 17.055, subdivision 117.133, subdivision 
59.16 	1; or
59.17 	(7) has been a resident for the last five years of one or more census tracts where, as 
59.18 	reported in the most recently completed decennial census published by the United States 
59.19 	Bureau of the Census, either:
59.20 	(i) the poverty rate was 20 percent or more; or
59.21 	(ii) the median family income did not exceed 80 percent of statewide median family 
59.22 	income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide 
59.23 	median family income or 80 percent of the median family income for that metropolitan 
59.24 	area.
59.25 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
59.26 	in the case of a business entity, every cooperative member or director, manager, and general 
59.27 	partner apply to at least 65 percent of the controlling ownership of the business entity.

59.28 	Sec. 61. [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
59.29 	(a) The office must classify licenses listed in section 342.10, clauses (1) to (10) and (13) 
59.30 	as:
59.31 	(1) available to social equity applicants who meet the requirements of section 342.17; 
59.32 	and
60.1 	(2) available to all applicants.
60.2 	(b) The office must classify any license issued to a social equity applicant as a social 
60.3 	equity license.

60.4 	Sec. 62. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 2, is amended 
60.5 	to read:
60.6 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
60.7 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
60.8 	in the applicant being vertically integrated in violation of the provisions of this chapter.
60.9 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses or,
60.10 	mezzobusiness licenses, or medical cannabis combination business licenses, or the issuance 
60.11 	of both lower-potency hemp edible manufacturer and lower-potency hemp edible retailer 
60.12 	licenses to the same person or entity.

60.13 	Sec. 63. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended 
60.14 	to read:
60.15 		Subd. 3.Application score; license priority review. (a) The office shall award points 
60.16 	to review each completed application for a license to operate a cannabis business in the 
60.17 	following categories:
60.18 	(1) status as a social equity applicant or as an applicant who is substantially similar to 
60.19 	a social equity applicant as described in paragraph (c);
60.20 	(2) status as a veteran or retired national guard applicant who does not meet the definition 
60.21 	of social equity applicant;
60.22 	(3) (1) security and record keeping;
60.23 	(4) (2) employee training plan;
60.24 	(5) (3) business plan and financial situation;
60.25 	(6) (4) labor and employment practices;
60.26 	(7) (5) knowledge and experience; and
60.27 	(8) (6) environmental plan.
60.28 	(b) The office may award additional points to an application if the license holder would 
60.29 	expand service to an underrepresented market, including but not limited to participation in 
60.30 	the medical cannabis program.
61.1 	(c) The office shall establish application materials permitting individual applicants to 
61.2 	demonstrate the impact that cannabis prohibition has had on that applicant, including but 
61.3 	not limited to the arrest or imprisonment of the applicant or a member of the applicant's 
61.4 	immediate family, and the office may award points to such applicants in the same manner 
61.5 	as points are awarded to social equity applicants.
61.6 	(d) (b) The office shall establish policies and guidelines, which the office must be made
61.7 	make available to the public, regarding the number of points available minimum 
61.8 	qualifications in each category and the basis for awarding those points. Status as a social 
61.9 	equity applicant must account for at least 20 percent of the total available points. In 
61.10 	determining the number of points to award to a cooperative or business applying as a social 
61.11 	equity applicant, the office shall consider the number or ownership percentage of cooperative 
61.12 	members, officers, directors, managers, and general partners who qualify as social equity 
61.13 	applicants criteria that the office uses to determine whether an applicant meets the minimum 
61.14 	qualifications in each category.
61.15 	(e) Consistent with the goals identified in subdivision 1, the office shall issue licenses 
61.16 	in each license category, giving priority to applicants who receive the highest score under 
61.17 	paragraphs (a) and (b). If there are insufficient licenses available for entities that receive 
61.18 	identical scores, the office shall utilize a lottery to randomly select license recipients from 
61.19 	among those entities.

61.20 	Sec. 64. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
61.21 	subdivision to read:
61.22 		Subd. 4.Maximum number of licenses. (a) Through as many licensing periods as the 
61.23 	office deems necessary, the office shall issue up to the maximum number of licenses in each 
61.24 	license category listed in paragraphs (e) and (f) to applicants that meet the minimum 
61.25 	qualifications in subdivision 3. After 24 months from the beginning of the license application 
61.26 	process, the office may adjust the maximum number of licenses of any type listed in this 
61.27 	subdivision based on market demand, consistent with the objectives in section 342.02, 
61.28 	subdivision 1, and the annual report required under section 342.04, paragraph (f).
61.29 	(b) If any applicant that meets the minimum qualifications in subdivision 3 is a city or 
61.30 	county seeking to establish, own, or operate a municipal cannabis store authorized under 
61.31 	section 342.32, subdivision 5, the office must issue a license to that applicant before issuing 
61.32 	any other licenses under this section or holding a lottery to randomly select license recipients. 
61.33 	Notwithstanding paragraph (f), a license issued to a city or county must not be counted 
61.34 	against the maximum number of licenses made available in an application period. If there 
62.1 	are insufficient licenses available for all applicants that meet the minimum qualifications 
62.2 	in subdivision 3, the office shall hold a lottery to randomly select license recipients from 
62.3 	among the applicants.
62.4 	(c) The office may issue as many licenses as the office deems necessary of a license 
62.5 	type that is not listed in this subdivision. The office is not required to issue a license for a 
62.6 	license type that is not listed in this subdivision.
62.7 	(d) Cannabis mezzobusiness license holders must earn no fewer than two distinctly 
62.8 	different endorsements for authorized actions under the license category within 18 months 
62.9 	of license issuance or the office may revoke the license holder's license or take appropriate 
62.10 	enforcement action.
62.11 	(e) The office is not required to issue licenses to meet the maximum number of licenses 
62.12 	that may be issued under paragraphs (f) and (g).
62.13 	(f) For licenses that are available to social equity applicants, the maximum number of 
62.14 	licenses that the office may issue are:
62.15 	(1) cannabis cultivator licenses, 25;
62.16 	(2) cannabis manufacturer licenses, 12;
62.17 	(3) cannabis retailer licenses, 100; and
62.18 	(4) cannabis mezzobusiness licenses, 50.
62.19 	(g) For licenses that are available to all applicants, the maximum number of licenses 
62.20 	that the office may issue are:
62.21 	(1) cannabis cultivator licenses, 25;
62.22 	(2) cannabis manufacturer licenses, 12;
62.23 	(3) cannabis retailer licenses, 100; and
62.24 	(4) cannabis mezzobusiness licenses, 50.
62.25 	(h) If the office holds a lottery as provided in paragraph (b), an applicant that meets the 
62.26 	minimum qualifications in subdivision 3 and is not selected in the lottery may request that 
62.27 	the office retain the application for subsequent application periods. If a qualified applicant 
62.28 	requests that the office retain an application, the office must retain the application for one 
62.29 	year after the date of the request. The office may request additional information from any 
62.30 	applicant whose application is retained if the office determines that the information is 
62.31 	necessary to determine if the applicant meets the requirements for a subsequent application 
63.1 	period. If the applicant does not provide the additional requested information within 14 
63.2 	calendar days of the office's request for information, the office may deny the application. 
63.3 	If the office announces an application period, any application retained by the office may be 
63.4 	granted a license or be entered in a lottery if the applicant amends an application or provides 
63.5 	additional information at the request of the office. The office must not charge an additional 
63.6 	application fee before granting a license to an applicant whose application was retained by 
63.7 	the office or entering an application retained by the office in a lottery. The office may 
63.8 	disqualify an application from retention if:
63.9 	(1) the applicant has violated an ownership or operational requirement in this chapter 
63.10 	or rules adopted pursuant to this chapter that would justify revocation or nonrenewal of a 
63.11 	license;
63.12 	(2) the applicant is disqualified from holding a license pursuant to section 342.15; or
63.13 	(3) the applicant is determined to be in arrears on property, business, or personal taxes.

63.14 	Sec. 65. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
63.15 	subdivision to read:
63.16 		Subd. 5.Conversion to hemp business license. (a) After the office adopts initial rules 
63.17 	pursuant to section 342.02, subdivision 5, the office may permit a person selling edible 
63.18 	cannabinoid products who has registered pursuant to section 151.72, subdivision 5b, to 
63.19 	convert the registration to a comparable hemp business license if:
63.20 	(1) the registration was active before the office adopted initial rules;
63.21 	(2) the person submits documentation to the office sufficient to meet the minimum 
63.22 	requirements in section 342.44;
63.23 	(3) the person pays the applicable application and licensing fee as required by section 
63.24 	342.11; and
63.25 	(4) the person is in good standing with the state.
63.26 	(b) A person selling edible cannabinoid products who has registered pursuant to section 
63.27 	151.72, subdivision 5b, and remains in good standing with the state may continue operations 
63.28 	under an active registration for the longer of:
63.29 	(1) 30 days after the date that the office begins accepting applications for hemp business 
63.30 	licenses; or
63.31 	(2) if the person submits an application for a hemp business license, until the office 
63.32 	makes a determination regarding the registrant's application.

64.1 	Sec. 66. Minnesota Statutes 2023 Supplement, section 342.19, is amended by adding a 
64.2 	subdivision to read:
64.3 		Subd. 6.Inspection of unlicensed businesses and facilities. (a) The office may inspect 
64.4 	any commercial premises that is not licensed under this chapter where cultivation, 
64.5 	manufacturing, processing, or sale of cannabis plants, cannabis flower, cannabis concentrate, 
64.6 	artificially derived cannabinoids, hemp-derived consumer products, or edible cannabinoid 
64.7 	products is taking place.
64.8 	(b) A representative of the office performing an inspection under this subdivision must 
64.9 	present appropriate credentials to the owner, operator, or agent in charge and clearly state 
64.10 	the purpose of the inspection.
64.11 	(c) After providing the notice required under paragraph (b), a representative of the office 
64.12 	may enter the commercial premises and perform any of the following to determine if any 
64.13 	person is engaging in activities that are regulated by this chapter and not authorized without 
64.14 	the possession of a license and to determine the appropriate penalty under section 342.09, 
64.15 	subdivision 6:
64.16 	(1) inspect and investigate the commercial premises;
64.17 	(2) inspect and copy records; and
64.18 	(3) question privately any employer, owner, operator, agent, or employee of the 
64.19 	commercial operation.
64.20 	(d) Entry of a commercial premises must take place during regular working hours or at 
64.21 	other reasonable times.
64.22 	(e) If the office finds any cannabis plant, cannabis flower, cannabis product, artificially 
64.23 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product on 
64.24 	the inspected commercial premises, the office may either immediately seize the item or 
64.25 	affix to the item a tag, withdrawal from distribution order, or other appropriate marking 
64.26 	providing notice that the cannabis plant, cannabis flower, cannabis product, artificially 
64.27 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product is, or 
64.28 	is suspected of being, possessed or distributed in violation of this chapter, and has been 
64.29 	detained or embargoed, and warning all persons not to remove or dispose of the item by 
64.30 	sale or otherwise until permission for removal or disposal is given by the office or the court. 
64.31 	It is unlawful for a person to remove or dispose of a detained or embargoed cannabis plant, 
64.32 	cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency hemp 
64.33 	edible, or hemp-derived consumer product by sale or otherwise without the office's or a 
65.1 	court's permission and each transaction may be treated as a sale for the purposes of imposing 
65.2 	a penalty pursuant to section 342.09, subdivision 6.
65.3 	(f) If the office has seized, detained, or embargoed any item pursuant to paragraph (e), 
65.4 	the office must:
65.5 	(1) petition the district court in the county in which the item was found for an order 
65.6 	authorizing destruction of the product; and
65.7 	(2) notify the county attorney in the county where the item was found of the office's 
65.8 	actions.
65.9 	(g) If the court finds that the seized, detained, or embargoed cannabis plant, cannabis 
65.10 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
65.11 	hemp-derived consumer product was possessed or distributed in violation of this chapter 
65.12 	or rules adopted under this chapter, the office may destroy the cannabis plant, cannabis 
65.13 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
65.14 	hemp-derived consumer product at the expense of the person who possessed or distributed 
65.15 	the item in violation of this chapter and all court costs, fees, storage, and other proper 
65.16 	expenses must be assessed against the person or the person's agent.
65.17 	(h) The provisions of subdivision 2, paragraph (f) apply to any analysis or examination 
65.18 	performed under this subdivision.
65.19 	(i) The authorization under paragraph (e) does not apply to any cannabis flower, cannabis 
65.20 	product, lower-potency hemp edible, or hemp-derived consumer product lawfully purchased 
65.21 	for personal use.

65.22 	Sec. 67. Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:
65.23 	342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.
65.24 		Subdivision 1.Registration required. Before receiving a retail operations endorsement 
65.25 	and making retail sales to customers or patients, a cannabis microbusiness with a retail 
65.26 	operations endorsement, cannabis mezzobusiness with a retail operations endorsement, 
65.27 	cannabis retailer, medical cannabis retailer, medical cannabis combination business, or 
65.28 	lower-potency hemp edible retailer must register with the city, town, or county in which 
65.29 	the retail establishment is located. A county may issue a registration in cases where a city 
65.30 	or town has provided consent for the county to issue the registration for the jurisdiction.
65.31 		Subd. 2.Registration fee. (a) A local unit of government may impose an initial retail 
65.32 	registration fee of $500 or up to half the amount of the applicable initial license fee under 
66.1 	section 342.11, whichever is less. The local unit of government may also impose a renewal 
66.2 	retail registration fee of $1,000 or up to half the amount of the applicable renewal license 
66.3 	fee under section 342.11, whichever is less. The initial registration fee shall include the fee 
66.4 	for initial registration and the first annual renewal. Any renewal fee imposed by the local 
66.5 	unit of government shall be charged at the time of the second renewal and each subsequent 
66.6 	annual renewal thereafter.
66.7 	(b) The local unit of government may not charge an application fee.
66.8 	(c) A cannabis business with a cannabis retailer license and a medical cannabis retailer 
66.9 	license for the same location may only be charged a single registration fee.
66.10 	(d) (c) Registration fees are nonrefundable.
66.11 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
66.12 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
66.13 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
66.14 	retailer combination business operating a retail location, or lower-potency hemp edible 
66.15 	retailer that:
66.16 	(1) has a valid license or license preapproval issued by the office;
66.17 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
66.18 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
66.19 	compliance check that the local unit of government performs; and
66.20 	(4) if applicable, is current on all property taxes and assessments at the location where 
66.21 	the retail establishment is located.
66.22 	(b) Before issuing a retail registration, the local unit of government may conduct a 
66.23 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
66.24 	compliance with the any applicable operation requirements and the limits on the types of 
66.25 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
66.26 	products that may be sold local ordinance established pursuant to section 342.13.
66.27 	(c) A local unit of government shall renew the retail registration of a cannabis business 
66.28 	or hemp business when the office renews the license of the cannabis business or hemp 
66.29 	business.
66.30 	(d) A retail registration issued under this section may not be transferred.
66.31 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
66.32 	checks of every cannabis business and hemp business with a retail registration issued by 
67.1 	the local unit of government. The checks During a compliance check, a local unit of 
67.2 	government shall assess a business's compliance with age verification requirements, the
67.3 	and compliance with any applicable operation requirements, and the applicable limits on 
67.4 	the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
67.5 	hemp-derived consumer products being sold local ordinance established pursuant to section 
67.6 	342.13.
67.7 	(b) The A local unit of government must conduct unannounced age verification 
67.8 	compliance checks of every cannabis business and hemp business at least once each calendar 
67.9 	year. Age verification compliance checks must involve persons at least 17 years of age but 
67.10 	under the age of 21 who, with the prior written consent of a parent or guardian if the person 
67.11 	is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis 
67.12 	products, lower-potency hemp edibles, or hemp-derived consumer products under the direct 
67.13 	supervision of a law enforcement officer or an employee of the local unit of government.
67.14 	(c) Checks to ensure compliance with the applicable operation requirements and the 
67.15 	limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
67.16 	hemp-derived consumer products that may be sold must be performed at least once each 
67.17 	calendar year and may be performed by a law enforcement officer or an employee of the 
67.18 	local unit of government.
67.19 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
67.20 	a local unit of government determines that a cannabis business or hemp business with a 
67.21 	retail registration issued by the local unit of government is not operating in compliance with 
67.22 	the requirements of this chapter a local ordinance authorized under section 342.13 or that 
67.23 	the operation of the business poses an immediate threat to the health or safety of the public, 
67.24 	the local unit of government may suspend the retail registration of the cannabis business or 
67.25 	hemp business. The local unit of government must immediately notify the office of the 
67.26 	suspension and shall include a description of the grounds for the suspension.
67.27 	(b) The office shall review the retail registration suspension and may order reinstatement 
67.28 	of the retail registration or take any action described in section 342.19 or 342.21.
67.29 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
67.30 	the license and operating privilege of the cannabis business or hemp business for a longer 
67.31 	period or revokes the license.
67.32 	(d) The local unit of government may reinstate the retail registration if the local unit of 
67.33 	government determines that any violation has been cured. The local unit of government 
67.34 	must reinstate the retail registration if the office orders reinstatement.
68.1 	(e) No cannabis microbusiness with a retail operations endorsement, cannabis 
68.2 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
68.3 	retailer, medical cannabis combination business, or lower-potency hemp edible retailer may 
68.4 	make any sale to a customer or patient without a valid retail registration with a local unit 
68.5 	of government and a valid endorsement from the office. A local unit of government may 
68.6 	impose a civil penalty of up to $2,000 for each violation of this paragraph.

68.7 	Sec. 68. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended 
68.8 	to read:
68.9 		Subdivision 1.Individuals under 21 years of age. (a) A cannabis business may not 
68.10 	employ an individual under 21 years of age and may not contract with an individual under 
68.11 	21 years of age if the individual's scope of work involves the handling of cannabis plants, 
68.12 	cannabis flower, artificially derived cannabinoids, or cannabinoid products.
68.13 	(b) A cannabis business may not permit an individual under 21 years of age to enter the 
68.14 	business premises other than entry by a patient person enrolled in the registry program.
68.15 	(c) A cannabis business may not sell or give cannabis flower, cannabis products, 
68.16 	lower-potency hemp edibles, or hemp-derived consumer products to an individual under 
68.17 	21 years of age unless the individual is a patient; registered designated caregiver; or a parent, 
68.18 	legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical 
68.19 	cannabis flower or medical cannabinoid products enrolled in the registry program and the 
68.20 	cannabis business holds a medical cannabis retail endorsement.

68.21 	Sec. 69. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended 
68.22 	to read:
68.23 		Subd. 2.Use of cannabis flower and products within a licensed cannabis business. (a) 
68.24 	A cannabis business may not permit an individual who is not an employee to consume 
68.25 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
68.26 	products within its licensed premises unless the business is licensed to permit on-site 
68.27 	consumption.
68.28 	(b) Except as otherwise provided in this subdivision, a cannabis business may not permit 
68.29 	an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles, 
68.30 	or hemp-derived consumer products within its licensed premises or while the employee is 
68.31 	otherwise engaged in activities within the course and scope of employment.
69.1 	(c) A cannabis business may permit an employee to use medical cannabis flower and 
69.2 	medical cannabinoid products if that individual is a patient enrolled in the registry program.
69.3 	(d) For quality control, employees of a licensed cannabis business may sample cannabis 
69.4 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products. 
69.5 	Employees may not interact directly with customers for at least three hours after sampling 
69.6 	a product. Employees may not consume more than three samples in a single 24-hour period. 
69.7 	All samples must be recorded in the statewide monitoring system.

69.8 	Sec. 70. Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a 
69.9 	subdivision to read:
69.10 		Subd. 1a.Cannabis research. An institution of higher education, any department or 
69.11 	program of an institution of higher education, and any entity working in partnership with 
69.12 	an institution of higher education may apply for a cannabis microbusiness license to conduct 
69.13 	cannabis crop research. A cannabis researcher with a cannabis microbusiness license may 
69.14 	perform activities identified in subdivision 1, clauses (1) to (9) and (13). Cannabis plants 
69.15 	and cannabis flower grown for research purposes must not be offered for sale or otherwise 
69.16 	enter the stream of commerce. As used in this subdivision, "institution of higher education" 
69.17 	has the meaning given in sections 135A.51, subdivision 5, and 136A.28, subdivision 6.

69.18 	Sec. 71. Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended 
69.19 	to read:
69.20 		Subd. 2.Size limitations. (a) A cannabis microbusiness that cultivates cannabis at an 
69.21 	indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust 
69.22 	plant canopy limits for licensed businesses upward to meet market demand consistent with 
69.23 	the goals identified in section 342.02, subdivision 1. In each licensing period, the office 
69.24 	may adjust plant canopy limits for licenses that will be issued in that period upward or 
69.25 	downward to meet market demand consistent with the goals identified in section 342.02, 
69.26 	subdivision 1, except that the office must not impose a limit of less than 5,000 square feet 
69.27 	of plant canopy.
69.28 	(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate 
69.29 	up to one-half acre of mature, flowering plants unless the office increases that limit. The 
69.30 	office may increase the limit to no more than one acre if the office determines that expansion 
69.31 	is for licensed businesses upward to meet market demand consistent with the goals identified 
69.32 	in section 342.02, subdivision 1. In each licensing period, the office may adjust the limit 
69.33 	for licenses that will be issued in that period upward or downward to meet market demand 
70.1 	consistent with the goals identified in section 342.02, subdivision 1, except that the office 
70.2 	must not impose a limit of less than one-half acre of mature, flowering plants.
70.3 	(c) The office shall establish a limit on the manufacturing of cannabis products, 
70.4 	lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness 
70.5 	that manufactures such products may perform. The limit must be equivalent to the amount 
70.6 	of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square 
70.7 	feet in a year, but may be increased if the office expands the allowable area of cultivation 
70.8 	under paragraph (a).
70.9 	(d) A cannabis microbusiness with the appropriate endorsement may operate one retail 
70.10 	location.

70.11 	Sec. 72. Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a 
70.12 	subdivision to read:
70.13 		Subd. 11.Transportation between facilities. A cannabis microbusiness may transport 
70.14 	immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially 
70.15 	derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, 
70.16 	and hemp-derived consumer products between facilities operated by the cannabis 
70.17 	microbusiness if the cannabis microbusiness:
70.18 	(1) provides the office with the information described in section 342.35, subdivision 2; 
70.19 	and
70.20 	(2) complies with the requirements of section 342.36.

70.21 	Sec. 73. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended 
70.22 	to read:
70.23 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
70.24 	cannabis mezzobusiness license may also hold a cannabis event organizer license and a 
70.25 	medical cannabis retailer license.
70.26 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
70.27 	cannabis mezzobusiness license may own or operate any other cannabis business or hemp 
70.28 	business or hold more than one cannabis mezzobusiness license.
70.29 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
70.30 	a business may hold applies to every cooperative member or every director, manager, and 
70.31 	general partner of a cannabis business.

71.1 	Sec. 74. Minnesota Statutes 2023 Supplement, section 342.29, is amended by adding a 
71.2 	subdivision to read:
71.3 		Subd. 10.Transportation between facilities. A cannabis mezzobusiness may transport 
71.4 	immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially 
71.5 	derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, 
71.6 	and hemp-derived consumer products between facilities operated by the cannabis 
71.7 	mezzobusiness if the cannabis mezzobusiness:
71.8 	(1) provides the office with the information described in section 342.35, subdivision 2; 
71.9 	and
71.10 	(2) complies with the requirements of section 342.36.

71.11 	Sec. 75. Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended 
71.12 	to read:
71.13 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
71.14 	cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis 
71.15 	cultivator license, medical cannabis producer license, license to grow industrial hemp, and 
71.16 	cannabis event organizer license.
71.17 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
71.18 	cannabis cultivator license may own or operate any other cannabis business or hemp business. 
71.19 	This prohibition does not prevent the transportation of cannabis flower from a cannabis 
71.20 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
71.21 	and located on the same premises.
71.22 	(c) The office by rule may limit the number of cannabis cultivator licenses a person, 
71.23 	cooperative, or business may hold.
71.24 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
71.25 	business may hold applies to every cooperative member or every director, manager, and 
71.26 	general partner of a cannabis business.

71.27 	Sec. 76. Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended 
71.28 	to read:
71.29 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
71.30 	cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis 
71.31 	cultivator license, a medical cannabis processor license, and a cannabis event organizer 
71.32 	license.
72.1 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
72.2 	cannabis manufacturer license may own or operate any other cannabis business or hemp 
72.3 	business. This prohibition does not prevent transportation of cannabis flower from a cannabis 
72.4 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
72.5 	and located on the same premises.
72.6 	(c) The office by rule may limit the number of cannabis manufacturer licenses that a 
72.7 	person or business may hold.
72.8 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
72.9 	a business may hold applies to every cooperative member or every director, manager, and 
72.10 	general partner of a cannabis business.

72.11 	Sec. 77. Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended 
72.12 	to read:
72.13 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
72.14 	cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis 
72.15 	retailer license, and a cannabis event organizer license.
72.16 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
72.17 	cannabis retailer license may own or operate any other cannabis business or hemp business.
72.18 	(c) No person, cooperative, or business may hold a license to own or operate more than 
72.19 	one cannabis retail business in one city and three retail businesses in one county.
72.20 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
72.21 	cooperative, or business may hold.
72.22 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
72.23 	business may hold applies to every cooperative member or every director, manager, and 
72.24 	general partner of a cannabis business.

72.25 	Sec. 78. Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended 
72.26 	to read:
72.27 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
72.28 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
72.29 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
72.30 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
72.31 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
72.32 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers, 
73.1 	medical cannabis processors, and industrial hemp growers to cannabis microbusinesses, 
73.2 	cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
73.3 	wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis 
73.4 	processors, medical cannabis retailers, and medical cannabis combination businesses and 
73.5 	perform other actions approved by the office.

73.6 	Sec. 79. Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended 
73.7 	to read:
73.8 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
73.9 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
73.10 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
73.11 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
73.12 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
73.13 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
73.14 	cultivators, medical cannabis processors, medical cannabis combination businesses, and 
73.15 	industrial hemp growers.

73.16 	Sec. 80. Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended 
73.17 	to read:
73.18 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
73.19 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
73.20 	combination businesses operating a retail location, and lower-potency hemp edible retailers, 
73.21 	including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use 
73.22 	cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived 
73.23 	consumer products to customers at a cannabis event.
73.24 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
73.25 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
73.26 	take place in a retail area as designated in the premises diagram.
73.27 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
73.28 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
73.29 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
73.30 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
73.31 	products to an individual under 21 years of age.
74.1 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
74.2 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
74.3 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
74.4 	products must be stored in a sample jar or display case and be accompanied by a label or 
74.5 	notice containing the information required to be affixed to the packaging or container 
74.6 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
74.7 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
74.8 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
74.9 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
74.10 	cannabis flower or adult-use cannabis product before purchase.
74.11 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
74.12 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
74.13 	and hemp-derived consumer products for sale at a cannabis event.
74.14 	(g) Authorized retailers may not:
74.15 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
74.16 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
74.17 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
74.18 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
74.19 	is legally permitted to possess;
74.20 	(3) sell medical cannabis flower or medical cannabinoid products;
74.21 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
74.22 	edibles, or hemp-derived consumer products; or
74.23 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
74.24 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
74.25 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
74.26 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
74.27 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
74.28 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
74.29 	locked container that is not accessible to the public. Such items being stored at a cannabis 
74.30 	event shall not be left unattended.
74.31 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
74.32 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
75.1 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
75.2 	the testing, packaging, and labeling of those items.
75.3 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
75.4 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
75.5 	system.

75.6 	Sec. 81. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended 
75.7 	to read:
75.8 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
75.9 	cannabis delivery service license may also hold a cannabis retailer license, a cannabis 
75.10 	wholesaler license, a cannabis transporter license, and a cannabis event organizer license, 
75.11 	and a medical cannabis retailer license subject to the ownership limitations that apply to 
75.12 	those licenses.
75.13 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
75.14 	cannabis delivery service license may own or operate any other cannabis business or hemp 
75.15 	business.
75.16 	(c) The office by rule may limit the number of cannabis delivery service licenses that a 
75.17 	person or business may hold.
75.18 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
75.19 	a business may hold applies to every cooperative member or every director, manager, and 
75.20 	general partner of a cannabis business.

75.21 	Sec. 82. Minnesota Statutes 2023 Supplement, section 342.46, subdivision 8, is amended 
75.22 	to read:
75.23 		Subd. 8.On-site consumption. (a) A lower-potency hemp edible retailer may permit 
75.24 	on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an 
75.25 	on-site consumption endorsement.
75.26 	(b) The office shall issue an on-site consumption endorsement to any lower-potency 
75.27 	hemp edible retailer that also holds an on-sale license issued under chapter 340A.
75.28 	(c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles 
75.29 	sold for on-site consumption comply with this chapter and rules adopted pursuant to this 
75.30 	chapter regarding testing.
76.1 	(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency 
76.2 	hemp edibles that are intended to be consumed as a beverage, must be served in the required 
76.3 	packaging, but may be removed from the products' packaging by customers and consumed 
76.4 	on site.
76.5 	(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may 
76.6 	be served outside of their the edibles' packaging provided that if the information that is 
76.7 	required to be contained on the label of a lower-potency hemp edible is posted or otherwise 
76.8 	displayed by the lower-potency hemp edible retailer. Hemp workers who serve beverages 
76.9 	under this paragraph are not required to obtain an edible cannabinoid product handler 
76.10 	endorsement under section 342.07, subdivision 3.
76.11 	(f) Food and beverages not otherwise prohibited by this subdivision may be prepared 
76.12 	and sold on site provided that if the lower-potency hemp edible retailer complies with all 
76.13 	relevant state and local laws, ordinances, licensing requirements, and zoning requirements.
76.14 	(g) A lower-potency hemp edible retailer may offer recorded or live entertainment 
76.15 	provided that if the lower-potency hemp edible retailer complies with all relevant state and 
76.16 	local laws, ordinances, licensing requirements, and zoning requirements.
76.17 	(h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible 
76.18 	retailer with an on-site consumption endorsement may not:
76.19 	(1) sell, give, furnish, or in any way procure for another lower-potency hemp edibles to 
76.20 	a customer who the lower-potency hemp edible retailer knows or reasonably should know 
76.21 	is intoxicated or has consumed alcohol within the previous five hours for the use of an 
76.22 	obviously intoxicated person;
76.23 	(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed 
76.24 	with an alcoholic beverage; or
76.25 	(3) permit lower-potency hemp edibles that have been removed from the products' 
76.26 	packaging to be removed from the premises of the lower-potency hemp edible retailer.

76.27 	Sec. 83. [342.465] LOWER-POTENCY HEMP EDIBLES; PROHIBITED CONDUCT.
76.28 	No person may sell, give, furnish, or in any way procure for another lower-potency hemp 
76.29 	edibles for the use of an obviously intoxicated person.

77.1 	Sec. 84. Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:
77.2 	342.51 MEDICAL CANNABIS RETAILERS ENDORSEMENTS.
77.3 		Subdivision 1.Endorsement; authorized actions. (a) The office may issue a medical 
77.4 	cannabis endorsement to a cannabis business authorizing the business to:
77.5 	(1) cultivate medical cannabis;
77.6 	(2) process medical cannabinoid products; or
77.7 	(3) sell or distribute medical cannabis flower and medical cannabinoid products to any 
77.8 	person authorized to receive medical cannabis flower or medical cannabinoid products.
77.9 	(b) The office must issue a medical cannabis cultivation endorsement to a cannabis 
77.10 	license holder if the license holder:
77.11 	(1) is authorized to cultivate cannabis;
77.12 	(2) submits a medical cannabis endorsement application to the office; and
77.13 	(3) otherwise meets all applicable requirements established by the office.
77.14 	(c) A medical cannabis cultivation endorsement entitles the license holder to grow 
77.15 	cannabis plants within the approved amount of space from seed or immature plant to mature 
77.16 	plant, harvest cannabis flower from a mature plant, package and label cannabis flower as 
77.17 	medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical 
77.18 	cannabis endorsement, and perform other actions approved by the office.
77.19 	(d) The office must issue a medical cannabis processor endorsement to a cannabis license 
77.20 	holder if the license holder:
77.21 	(1) is authorized to manufacture cannabis products;
77.22 	(2) submits a medical cannabis endorsement application to the office; and
77.23 	(3) otherwise meets all applicable requirements established by the office.
77.24 	(e) A medical cannabis processor endorsement entitles the license holder to:
77.25 	(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, 
77.26 	and hemp concentrate from cannabis businesses with a medical cannabis cultivator 
77.27 	endorsement or a medical cannabis processor endorsement;
77.28 	(2) purchase hemp plant parts from industrial hemp growers;
77.29 	(3) make cannabis concentrate from medical cannabis flower;
78.1 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
78.2 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
78.3 	(5) manufacture medical cannabinoid products;
78.4 	(6) package and label medical cannabinoid products for sale to cannabis businesses with 
78.5 	a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and
78.6 	(7) perform other actions approved by the office.
78.7 	(f) The office must issue a medical cannabis retailer endorsement to a cannabis license 
78.8 	holder if the license holder:
78.9 	(1) submits a medical cannabis retail endorsement application to the office;
78.10 	(2) has at least one employee who earned a medical cannabis consultant certificate issued 
78.11 	by the office and has completed the required training or has at least one employee who is 
78.12 	a licensed pharmacist under chapter 151; and
78.13 	(3) otherwise meets all applicable requirements established by the office.
78.14 	(g) A medical cannabis retailer license retail endorsement entitles the license holder to 
78.15 	purchase medical cannabis flower and medical cannabinoid products from medical cannabis 
78.16 	cultivators and medical cannabis processors cannabis businesses with medical cannabis 
78.17 	cultivator endorsements and medical cannabis processor endorsements, and sell or distribute 
78.18 	medical cannabis flower and, medical cannabinoid products, and associated paraphernalia
78.19 	to any person authorized to receive medical cannabis flower or medical cannabinoid products.
78.20 	(b) (h) A medical cannabis retailer license holder business with a medical cannabis retail 
78.21 	endorsement must verify that all medical cannabis flower and medical cannabinoid products 
78.22 	have passed safety, potency, and consistency testing at a cannabis testing facility approved 
78.23 	by the office for the testing of medical cannabis flower and medical cannabinoid products 
78.24 	before the medical cannabis retailer cannabis business with a medical cannabis retail 
78.25 	endorsement may distribute the medical cannabis flower or medical cannabinoid product 
78.26 	to any person authorized to receive medical cannabis flower or medical cannabinoid products
78.27 	enrolled in the registry program.
78.28 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
78.29 	or medical cannabinoid products, a medical cannabis retailer licensee to a person enrolled 
78.30 	in the registry program, an employee with a valid medical cannabis consultant certificate 
78.31 	issued by the office or a licensed pharmacist under chapter 151 must:
78.32 	(1) review and confirm the patient's enrollment in the registry verification program;
79.1 	(2) verify that the person requesting the distribution of medical cannabis flower or 
79.2 	medical cannabinoid products is the patient, the patient's registered designated caregiver, 
79.3 	or the patient's parent, legal guardian, or spouse using the procedures specified in section 
79.4 	152.11, subdivision 2d established by the office;
79.5 	(3) ensure that a pharmacist employee of the medical cannabis retailer has consulted 
79.6 	with the patient if required according to subdivision 3; and
79.7 	(3) provide consultation to the patient to determine the proper medical cannabis flower 
79.8 	or medical cannabinoid product, dosage, and paraphernalia for the patient if required under 
79.9 	subdivision 3;
79.10 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
79.11 	product that includes recommended dosage requirements and other information as required 
79.12 	by rules adopted by the office.; and
79.13 	(5) provide the patient with any other information required by the office.
79.14 	(b) A cannabis business with a medical cannabis retailer retail endorsement may not 
79.15 	deliver medical cannabis flower or medical cannabinoid products to a person enrolled in 
79.16 	the registry program unless the cannabis business with a medical cannabis retailer retail 
79.17 	endorsement also holds a cannabis delivery service license. The delivery of medical cannabis 
79.18 	flower and medical cannabinoid products are subject to the provisions of section 342.42.
79.19 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
79.20 	cannabinoid products. (a) A cannabis worker who is employed by a cannabis business 
79.21 	with a medical cannabis retailer and retail endorsement who is licensed as a pharmacist 
79.22 	pursuant to chapter 151shall be or certified as a medical cannabis consultant by the office 
79.23 	is the only person who may give final approval for the distribution of medical cannabis 
79.24 	flower and medical cannabinoid products. Prior to the distribution of medical cannabis 
79.25 	flower or medical cannabinoid products, a pharmacist or certified medical cannabis consultant 
79.26 	employed by the cannabis business with a medical cannabis retailer retail endorsement must 
79.27 	consult with the patient to determine the proper type of medical cannabis flower, medical 
79.28 	cannabinoid product, or medical cannabis paraphernalia, and the proper dosage for the 
79.29 	patient after reviewing the range of chemical compositions of medical cannabis flower or 
79.30 	medical cannabinoid product. intended for distribution:
79.31 	(1) if the patient is purchasing the medical cannabis flower or medical cannabinoid 
79.32 	product for the first time;
80.1 	(2) if the patient purchases medical cannabis flower or a medical cannabinoid product 
80.2 	that the patient must administer using a different method than the patient's previous method 
80.3 	of administration;
80.4 	(3) if the patient purchases medical cannabis flower or a medical cannabinoid product 
80.5 	with a cannabinoid concentration of at least double the patient's prior dosage; or
80.6 	(4) upon the request of the patient.
80.7 	(b) For purposes of this subdivision, a consultation may be conducted remotely by secure 
80.8 	videoconference, telephone, or other remote means, as long as:
80.9 	(1) the pharmacist or consultant engaging in the consultation is able to confirm the 
80.10 	identity of the patient; and
80.11 	(2) the consultation adheres to patient privacy requirements that apply to health care 
80.12 	services delivered through telemedicine.
80.13 	(b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the 
80.14 	distribution of medical cannabis flower or medical cannabinoid products when a medical 
80.15 	cannabis retailer is distributing medical cannabis flower or medical cannabinoid products 
80.16 	to a patient according to a patient-specific dosage plan established with that medical cannabis 
80.17 	retailer and is not modifying the dosage or product being distributed under that plan. Medical 
80.18 	cannabis flower or medical cannabinoid products distributed under this paragraph must be 
80.19 	distributed by a pharmacy technician employed by the medical cannabis retailer.
80.20 		Subd. 4.90-day supply. A medical cannabis retailer shall not distribute more than a 
80.21 	90-day supply of medical cannabis flower or medical cannabinoid products to a patient, 
80.22 	registered designated caregiver, or parent, legal guardian, or spouse of a patient according 
80.23 	to the dosages established for the individual patient.
80.24 		Subd. 5.Distribution to recipient in a motor vehicle. A cannabis business with a 
80.25 	medical cannabis retailer retail endorsement may distribute medical cannabis flower and 
80.26 	medical cannabinoid products to a patient, registered designated caregiver, or parent, legal 
80.27 	guardian, or spouse of a patient person enrolled in the registry program who is at a dispensary 
80.28 	location but remains in a motor vehicle, provided that if:
80.29 	(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid 
80.30 	products in a designated zone that is as close as feasible to the front door of the facility;
80.31 	(2) the cannabis business with a medical cannabis retailer retail endorsement ensures 
80.32 	that the receipt of payment and distribution of medical cannabis flower and medical 
81.1 	cannabinoid products are visually recorded by a closed-circuit television surveillance camera 
81.2 	and provides any other necessary security safeguards;
81.3 	(3) the cannabis business with a medical cannabis retailer retail endorsement does not 
81.4 	store medical cannabis flower or medical cannabinoid products outside a restricted access 
81.5 	area and staff transport medical cannabis flower and medical cannabinoid products from a 
81.6 	restricted access area to the designated zone for distribution only after confirming that the 
81.7 	patient, designated caregiver, or parent, guardian, or spouse person enrolled in the registry 
81.8 	program has arrived in the designated zone;
81.9 	(4) the payment for and distribution of medical cannabis flower and medical cannabinoid 
81.10 	products take place only after a pharmacist consultation takes place, if required under 
81.11 	subdivision 3 meeting the requirements in subdivision 2;
81.12 	(5) immediately following the distribution of medical cannabis flower or medical 
81.13 	cannabinoid products, staff enter record the transaction in the statewide monitoring system; 
81.14 	and
81.15 	(6) immediately following the distribution of medical cannabis flower and medical 
81.16 	cannabinoid products, staff take the payment received into the facility.

81.17 	EFFECTIVE DATE. This section is effective July 1, 2025.

81.18 	Sec. 85. Minnesota Statutes 2023 Supplement, section 342.515, subdivision 1, is amended 
81.19 	to read:
81.20 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
81.21 	medical cannabis combination business license is prohibited from owning or operating any 
81.22 	other cannabis business or hemp business. Notwithstanding any law to the contrary, issuance 
81.23 	of a medical cannabis combination business license to a medical cannabis manufacturer 
81.24 	registered pursuant to section 152.25 cancels the medical cannabis manufacturer registration.
81.25 	(b) A person or business may hold only one medical cannabis combination business 
81.26 	license.
81.27 	(c) A medical cannabis combination business license entitles the license holder to perform 
81.28 	any or all of the following within the limits established by this section:
81.29 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
81.30 	adult-use cannabis flower and medical cannabis flower from a mature plant;
81.31 	(2) make cannabis concentrate;
82.1 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
82.2 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
82.3 	(4) manufacture artificially derived cannabinoids;
82.4 	(5) manufacture medical cannabinoid products;
82.5 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
82.6 	hemp-derived consumer products for public consumption;
82.7 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
82.8 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
82.9 	a medical cannabis cultivator, or another medical cannabis combination business;
82.10 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
82.11 	under chapter 18K;
82.12 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
82.13 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
82.14 	cannabis wholesaler, a medical cannabis processor, or another medical cannabis combination 
82.15 	business;
82.16 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
82.17 	18K;
82.18 	(11) package and label medical cannabis flower and medical cannabinoid products for 
82.19 	sale to cannabis businesses with a medical cannabis processors processor endorsement, 
82.20 	cannabis businesses with a medical cannabis retailers retail endorsement, other medical 
82.21 	cannabis combination businesses, and patients enrolled persons in the registry program, 
82.22 	registered designated caregivers, and parents, legal guardians, and spouses of an enrolled 
82.23 	patient;
82.24 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
82.25 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
82.26 	(13) sell medical cannabis flower and medical cannabinoid products to patients enrolled 
82.27 	in the registry program, registered designated caregivers, and parents, legal guardians, and 
82.28 	spouses of an enrolled patient;
82.29 	(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
82.30 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
82.31 	other products authorized by law to other cannabis businesses and to customers; and
82.32 	(15) perform other actions approved by the office.

83.1 	Sec. 86. Minnesota Statutes 2023 Supplement, section 342.515, is amended by adding a 
83.2 	subdivision to read:
83.3 		Subd. 7.Transportation between facilities. A medical cannabis combination business 
83.4 	may transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
83.5 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
83.6 	edibles, and hemp-derived consumer products between facilities operated by the medical 
83.7 	cannabis combination business if the medical cannabis combination business:
83.8 	(1) provides the office with the information described in section 342.35, subdivision 2; 
83.9 	and
83.10 	(2) complies with the requirements of section 342.36.

83.11 	Sec. 87. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended 
83.12 	to read:
83.13 		Subdivision 1.Administration. The Division of Medical Cannabis office must administer 
83.14 	the medical cannabis patient registry program.

83.15 	EFFECTIVE DATE. This section is effective July 1, 2025.

83.16 	Sec. 88. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended 
83.17 	to read:
83.18 		Subd. 2.Application procedure for patients. (a) A patient seeking to enroll in the 
83.19 	registry program must submit to the Division of Medical Cannabis office an application 
83.20 	established by the Division of Medical Cannabis office and a copy of the certification 
83.21 	specified in paragraph (b) or, if the patient is a veteran who receives care from the United 
83.22 	States Department of Veterans Affairs, the information required pursuant to subdivision 3. 
83.23 	The patient must provide at least the following information in the application:
83.24 	(1) the patient's name, mailing address, and date of birth;
83.25 	(2) the name, mailing address, and telephone number of the patient's health care 
83.26 	practitioner;
83.27 	(3) the name, mailing address, and date of birth of the patient's registered designated 
83.28 	caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, 
83.29 	or spouse will be acting as the patient's caregiver;
83.30 	(4) a disclosure signed by the patient that includes:
84.1 	(i) a statement that, notwithstanding any law to the contrary, the office of Cannabis 
84.2 	Management, the Division of Medical Cannabis, or an employee of the office of Cannabis 
84.3 	Management or Division of Medical Cannabis may not be held civilly or criminally liable 
84.4 	for any injury, loss of property, personal injury, or death caused by an act or omission while 
84.5 	acting within the employee's scope of office or employment under this section; and
84.6 	(ii) the patient's acknowledgment that enrollment in the registry program is conditional 
84.7 	on the patient's agreement to meet all other requirements of this section; and
84.8 	(5) all other information required by the Division of Medical Cannabis office.
84.9 	(b) As part of the application under this subdivision, a patient must submit a copy of a 
84.10 	certification from the patient's health care practitioner that is dated within 90 days prior to 
84.11 	the submission of the application and that certifies that the patient has been diagnosed with 
84.12 	a qualifying medical condition.
84.13 	(c) A patient's health care practitioner may submit a statement to the Division of Medical 
84.14 	Cannabis office declaring that the patient is no longer diagnosed with a qualifying medical 
84.15 	condition. Within 30 days after receipt of a statement from a patient's health care practitioner, 
84.16 	the Division of Medical Cannabis office must provide written notice to a patient stating that 
84.17 	the patient's enrollment in the registry program will be revoked in 30 days unless the patient 
84.18 	submits a certification from a health care practitioner that the patient is currently diagnosed 
84.19 	with a qualifying medical condition or, if the patient is a veteran, the patient submits 
84.20 	confirmation that the patient is currently diagnosed with a qualifying medical condition in 
84.21 	a form and manner consistent with the information required for an application made pursuant 
84.22 	to subdivision 3. If the Division of Medical Cannabis office revokes a patient's enrollment 
84.23 	in the registry program pursuant to this paragraph, the division must provide notice to the 
84.24 	patient and to the patient's health care practitioner.

84.25 	EFFECTIVE DATE. This section is effective July 1, 2025.

84.26 	Sec. 89. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended 
84.27 	to read:
84.28 		Subd. 3.Application procedure for veterans. (a) The Division of Medical Cannabis
84.29 	office shall establish an alternative certification procedure for veterans who receive care 
84.30 	from the United States Department of Veterans Affairs to confirm that the veteran has been 
84.31 	diagnosed with a qualifying medical condition enroll in the patient registry program.
84.32 	(b) A patient who is also a veteran receiving care from the United States Department of 
84.33 	Veterans Affairs and is seeking to enroll in the registry program must submit to the Division 
85.1 	of Medical Cannabis office a copy of the patient's veteran health identification card issued 
85.2 	by the United States Department of Veterans Affairs and an application established by the 
85.3 	Division of Medical Cannabis that includes the information identified in subdivision 2, 
85.4 	paragraph (a), and the additional information required by the Division of Medical Cannabis 
85.5 	to certify that the patient has been diagnosed with a qualifying medical condition office to 
85.6 	confirm that the veteran has been diagnosed with a condition that may benefit from the 
85.7 	therapeutic use of medical cannabis.

85.8 	EFFECTIVE DATE. This section is effective July 1, 2025.

85.9 	Sec. 90. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended 
85.10 	to read:
85.11 		Subd. 4.Enrollment; denial of enrollment; revocation. (a) Within 30 days after the 
85.12 	receipt of an application and certification or other documentation of a diagnosis with a 
85.13 	qualifying medical condition, the Division of Medical Cannabis office must approve or 
85.14 	deny a patient's enrollment in the registry program. If the Division of Medical Cannabis
85.15 	office approves a patient's enrollment in the registry program, the office must provide notice 
85.16 	to the patient and to the patient's health care practitioner.
85.17 	(b) The office may deny a patient's enrollment in the registry program must only be 
85.18 	denied only if the patient:
85.19 	(1) does not submit a certification from a health care practitioner or, if the patient is a 
85.20 	veteran, the documentation required under subdivision 3 that the patient has been diagnosed 
85.21 	with a qualifying medical condition;
85.22 	(2) has not signed the disclosure required in subdivision 2;
85.23 	(3) does not provide the information required by the Division of Medical Cannabis
85.24 	office;
85.25 	(4) provided false information on the application; or
85.26 	(5) at the time of application, is also enrolled in a federally approved clinical trial for 
85.27 	the treatment of a qualifying medical condition with medical cannabis.
85.28 	(c) If the Division of Medical Cannabis office denies a patient's enrollment in the registry 
85.29 	program, the Division of Medical Cannabis office must provide written notice to a patient 
85.30 	of all reasons for denying enrollment. Denial of enrollment in the registry program is 
85.31 	considered a final decision of the office and is subject to judicial review under chapter 14.
86.1 	(d) The office may revoke a patient's enrollment in the registry program may be revoked
86.2 	only:
86.3 	(1) pursuant to subdivision 2, paragraph (c);
86.4 	(2) upon the death of the patient;
86.5 	(3) if the patient's certifying health care practitioner has filed a declaration under 
86.6 	subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the 
86.7 	patient does not submit another certification within 30 days;
86.8 	(4) if the patient does not comply with subdivision 6; or
86.9 	(5) if the patient intentionally sells or diverts medical cannabis flower or medical 
86.10 	cannabinoid products in violation of this chapter.
86.11 	(e) If the office has revoked a patient's enrollment in the registry program has been 
86.12 	revoked due to a violation of subdivision 6, the patient may apply for enrollment 12 months 
86.13 	after the date on which the patient's enrollment was revoked. The office must process such 
86.14 	an application in accordance with this subdivision.

86.15 	EFFECTIVE DATE. This section is effective July 1, 2025.

86.16 	Sec. 91. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended 
86.17 	to read:
86.18 		Subd. 5.Registry verification. When a patient is enrolled in the registry program, the 
86.19 	Division of Medical Cannabis office must assign the patient a patient registry number and 
86.20 	must issue the patient and the patient's registered designated caregiver, parent, legal guardian, 
86.21 	or spouse, if applicable, a registry verification. The Division of Medical Cannabis office
86.22 	must also make the registry verification available to medical cannabis retailers businesses 
86.23 	with a medical cannabis retail endorsement. The registry verification must include:
86.24 	(1) the patient's name and date of birth;
86.25 	(2) the patient registry number assigned to the patient; and
86.26 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
86.27 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
86.28 	spouse will act as a caregiver.

86.29 	EFFECTIVE DATE. This section is effective July 1, 2025.

87.1 	Sec. 92. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended 
87.2 	to read:
87.3 		Subd. 9.Registered designated caregiver. (a) The Division of Medical Cannabis office
87.4 	must register a designated caregiver for a patient if the patient requires assistance in 
87.5 	administering medical cannabis flower or medical cannabinoid products or in; obtaining 
87.6 	medical cannabis flower, medical cannabinoid products, or medical cannabis paraphernalia 
87.7 	from a cannabis business with a medical cannabis retailer retail endorsement; or cultivating 
87.8 	cannabis plants as permitted by section 342.09, subdivision 2.
87.9 	(b) In order to serve as a designated caregiver, a person must:
87.10 	(1) be at least 18 years of age;
87.11 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid 
87.12 	products for purposes of assisting the patient; and
87.13 	(3) agree that if the application is approved, the person will not serve as a registered 
87.14 	designated caregiver for more than six registered patients at one time. Patients who reside 
87.15 	in the same residence count as one patient.
87.16 	(c) The office shall conduct a criminal background check on the designated caregiver 
87.17 	prior to registration to ensure that the person does not have a conviction for a disqualifying 
87.18 	felony offense. Any cost of the background check shall be paid by the person seeking 
87.19 	registration as a designated caregiver. A designated caregiver must have the criminal 
87.20 	background check renewed every two years.
87.21 	(d) (c) Nothing in this section shall be construed to prevent a registered designated 
87.22 	caregiver from being enrolled in the registry program as a patient and possessing and 
87.23 	administering medical cannabis flower or medical cannabinoid products as a patient.
87.24 	(d) Notwithstanding any law to the contrary, a registered designated caregiver approved 
87.25 	to assist a patient enrolled in the registry program with obtaining medical cannabis flower 
87.26 	may cultivate cannabis plants on behalf of one patient. A registered designated caregiver 
87.27 	may grow up to eight cannabis plants for the patient household that the registered designated 
87.28 	caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled 
87.29 	in the registry program directs the patient's registered designated caregiver to cultivate 
87.30 	cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate 
87.31 	cannabis plants to the registered designated caregiver and the patient is prohibited from 
87.32 	cultivating cannabis plants for personal use. Nothing in this paragraph limits the right of a 
87.33 	registered designated caregiver cultivating cannabis plants on behalf of a patient enrolled 
88.1 	in the registry program to also cultivate cannabis plants for personal use pursuant to section 
88.2 	342.09, subdivision 2.

88.3 	EFFECTIVE DATE. This section is effective July 1, 2025.

88.4 	Sec. 93. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended 
88.5 	to read:
88.6 		Subd. 11.Notice of change of name or address. Patients and registered designated 
88.7 	caregivers must notify the Division of Medical Cannabis office of any address or name 
88.8 	change within 30 days of the change having occurred. A patient or registered designated 
88.9 	caregiver is subject to a $100 fine for failure to notify the office of the change.

88.10 	EFFECTIVE DATE. This section is effective July 1, 2025.

88.11 	Sec. 94. Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:
88.12 	342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; APPROVAL OF 
88.13 	CANNABINOID PRODUCTS FOR REGISTRY PROGRAM.
88.14 	The office may add an allowable form of medical cannabinoid product, and may add or 
88.15 	modify a qualifying medical condition upon its own initiative, upon a petition from a member 
88.16 	of the public or from the Cannabis Advisory Council or as directed by law. The office must 
88.17 	evaluate all petitions and must make the addition or modification if the office determines 
88.18 	that the addition or modification is warranted by the best available evidence and research. 
88.19 	If the office wishes to add an allowable form or add or modify a qualifying medical condition, 
88.20 	the office must notify the chairs and ranking minority members of the legislative committees 
88.21 	and divisions with jurisdiction over health finance and policy by January 15 of the year in 
88.22 	which the change becomes effective. In this notification, the office must specify the proposed 
88.23 	addition or modification, the reasons for the addition or modification, any written comments 
88.24 	received by the office from the public about the addition or modification, and any guidance 
88.25 	received from the Cannabis Advisory Council. An addition or modification by the office 
88.26 	under this subdivision becomes effective on August 1 of that year unless the legislature by 
88.27 	law provides otherwise.

88.28 	EFFECTIVE DATE. This section is effective July 1, 2025.

89.1 	Sec. 95. Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:
89.2 	342.54 DUTIES OF DIVISION OF MEDICAL CANNABIS OFFICE OF 
89.3 	CANNABIS MANAGEMENT; REGISTRY PROGRAM.
89.4 		Subdivision 1.Duties related to health care practitioners. The Division of Medical 
89.5 	Cannabis office must:
89.6 	(1) provide notice of the registry program to health care practitioners in the state;
89.7 	(2) allow health care practitioners to participate in the registry program if they request 
89.8 	to participate and meet the program's requirements;
89.9 	(3) provide explanatory information and assistance to health care practitioners to 
89.10 	understand the nature of the therapeutic use of medical cannabis flower and medical 
89.11 	cannabinoid products within program requirements;
89.12 	(4) make available to participating health care practitioners a certification form in which 
89.13 	a health care practitioner certifies that a patient has a qualifying medical condition; and
89.14 	(5) supervise the participation of health care practitioners in the registry reporting system 
89.15 	in which health care practitioners report patient treatment and health records information 
89.16 	to the office in a manner that ensures stringent security and record keeping requirements 
89.17 	and that prevents the unauthorized release of private data on individuals as defined in section 
89.18 	13.02.
89.19 		Subd. 2.Duties related to the registry program. The Division of Medical Cannabis
89.20 	office must:
89.21 	(1) administer the registry program according to section 342.52;
89.22 	(2) provide information to patients enrolled in the registry program on the existence of 
89.23 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
89.24 	with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 
89.25 	in the registry program;
89.26 	(3) maintain safety criteria with which patients must comply as a condition of participation 
89.27 	in the registry program to prevent patients from undertaking any task under the influence 
89.28 	of medical cannabis flower or medical cannabinoid products that would constitute negligence 
89.29 	or professional malpractice;
89.30 	(4) review and publicly report on existing medical and scientific literature regarding the 
89.31 	range of recommended dosages for each qualifying medical condition, the range of chemical 
89.32 	compositions of medical cannabis flower and medical cannabinoid products that will likely 
90.1 	be medically beneficial for each qualifying medical condition, and any risks of noncannabis 
90.2 	drug interactions. This information must be updated by December 1 of each yearevery three 
90.3 	years. The office may consult with an independent laboratory under contract with the office 
90.4 	or other experts in reporting and updating this information; and
90.5 	(5) annually consult with cannabis businesses about medical cannabis that the businesses 
90.6 	cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis
90.7 	office website a list of the medical cannabis flower and medical cannabinoid products offered 
90.8 	for sale by each cannabis business with a medical cannabis retailer endorsement.
90.9 		Subd. 3.Research. (a) The Division of Medical Cannabis office must conduct or contract 
90.10 	with a third party to conduct research and studies using data from health records submitted 
90.11 	to the registry program under section 342.55, subdivision 2, and data submitted to the registry 
90.12 	program under section 342.52, subdivisions 2 and 3. If the division office contracts with a 
90.13 	third party for research and studies, the third party must provide the division office with 
90.14 	access to all research and study results. The division office must submit reports on 
90.15 	intermediate or final research results to the legislature and major scientific journals. All 
90.16 	data used by the division office or a third party under this subdivision must be used or 
90.17 	reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed 
90.18 	publication of research or in the creation of summary data, as defined in section 13.02, 
90.19 	subdivision 19.
90.20 	(b) The Division of Medical Cannabis office may submit medical research based on the 
90.21 	data collected under sections 342.55, subdivision 2, and data collected through the statewide 
90.22 	monitoring system to any federal agency with regulatory or enforcement authority over 
90.23 	medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness 
90.24 	of medical cannabis flower or medical cannabinoid products for treating or alleviating the 
90.25 	symptoms of a qualifying medical condition.

90.26 	EFFECTIVE DATE. This section is effective July 1, 2024.

90.27 	Sec. 96. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended 
90.28 	to read:
90.29 		Subdivision 1.Health care practitioner duties before patient enrollment. Before a 
90.30 	patient's enrollment in the registry program, a health care practitioner must:
90.31 	(1) determine, in the health care practitioner's medical judgment, whether a patient has 
90.32 	a qualifying medical condition and, if so determined, provide the patient with a certification 
90.33 	of that diagnosis;
91.1 	(2) advise patients, registered designated caregivers, and parents, legal guardians, and 
91.2 	spouses acting as caregivers of any nonprofit patient support groups or organizations;
91.3 	(3) provide to patients explanatory information from the Division of Medical Cannabis
91.4 	office, including information about the experimental nature of the therapeutic use of medical 
91.5 	cannabis flower and medical cannabinoid products; the possible risks, benefits, and side 
91.6 	effects of the proposed treatment; and the application and other materials from the office;
91.7 	(4) provide to patients a Tennessen warning as required under section 13.04, subdivision 
91.8 	2; and
91.9 	(5) agree to continue treatment of the patient's qualifying medical condition and to report 
91.10 	findings to the Division of Medical Cannabis office.

91.11 	EFFECTIVE DATE. This section is effective July 1, 2025.

91.12 	Sec. 97. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended 
91.13 	to read:
91.14 		Subd. 2.Duties upon patient's enrollment in registry program. Upon receiving 
91.15 	notification from the Division of Medical Cannabis office of the patient's enrollment in the 
91.16 	registry program, a health care practitioner must:
91.17 	(1) participate in the patient registry reporting system under the guidance and supervision 
91.18 	of the Division of Medical Cannabis office;
91.19 	(2) report to the Division of Medical Cannabis office patient health records throughout 
91.20 	the patient's ongoing treatment in a manner determined by the office and in accordance with 
91.21 	subdivision 4;
91.22 	(3) determine on a yearly basis, every three years, if the patient continues to have a 
91.23 	qualifying medical condition and, if so, issue the patient a new certification of that diagnosis. 
91.24 	The patient assessment conducted under this clause may be conducted via telehealth, as 
91.25 	defined in section 62A.673, subdivision 2; and
91.26 	(4) otherwise comply with requirements established by the office of Cannabis 
91.27 	Management and the Division of Medical Cannabis.

91.28 	EFFECTIVE DATE. This section is effective July 1, 2024.

92.1 	Sec. 98. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended 
92.2 	to read:
92.3 		Subdivision 1.Limitations on consumption; locations of consumption. (a) Nothing 
92.4 	in sections 342.47 342.51 to 342.60 permits any person to engage in, and does not prevent 
92.5 	the imposition of any civil, criminal, or other penalties for:
92.6 	(1) undertaking a task under the influence of medical cannabis flower or medical 
92.7 	cannabinoid products that would constitute negligence or professional malpractice;
92.8 	(2) possessing or consuming medical cannabis flower or medical cannabinoid products:
92.9 	(i) on a school bus or van;
92.10 	(ii) in a correctional facility;
92.11 	(iii) in a state-operated treatment program, including the Minnesota sex offender program; 
92.12 	or
92.13 	(iv) on the grounds of a child care facility or family or group family day care program;
92.14 	(3) vaporizing or smoking medical cannabis:
92.15 	(i) on any form of public transportation;
92.16 	(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would 
92.17 	be inhaled by a minor; or
92.18 	(iii) in any public place, including any indoor or outdoor area used by or open to the 
92.19 	general public or a place of employment, as defined in section 144.413, subdivision 1b; and
92.20 	(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft, 
92.21 	train, or motorboat or working on transportation property, equipment, or facilities while 
92.22 	under the influence of medical cannabis flower or a medical cannabinoid product.
92.23 	(b) Except for the use of medical cannabis flower or medical cannabinoid products, the 
92.24 	vaporizing or smoking of cannabis flower, cannabis products, artificially derived 
92.25 	cannabinoids, or hemp-derived consumer products is prohibited in a multifamily housing 
92.26 	building, including balconies and patios appurtenant thereto. A violation of this paragraph 
92.27 	is punishable through a civil administrative fine in an amount of $250.

92.28 	EFFECTIVE DATE. This section is effective July 1, 2025.

93.1 	Sec. 99. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended 
93.2 	to read:
93.3 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
93.4 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
93.5 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
93.6 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
93.7 	144; and other health care facilities licensed by the commissioner of health or the 
93.8 	commissioner of human services may adopt reasonable restrictions on the use of medical 
93.9 	cannabis flower or medical cannabinoid products by a patient enrolled in the registry program 
93.10 	who resides at or is actively receiving treatment or care at the facility. The restrictions may 
93.11 	include a provision that the facility must not store or maintain a patient's supply of medical 
93.12 	cannabis flower or medical cannabinoid products on behalf of the patient; that a patient 
93.13 	store the patient's supply of medical cannabis flower or medicinal cannabinoid products in 
93.14 	a locked container accessible only to the patient, the patient's designated caregiver, or the 
93.15 	patient's parent, legal guardian, or spouse; that the facility is not responsible for providing 
93.16 	medical cannabis for patients; and that medical cannabis flower or medical cannabinoid 
93.17 	products are used only in a location specified by the facility or provider. Nothing in this 
93.18 	subdivision requires facilities and providers listed in this subdivision to adopt such 
93.19 	restrictions.
93.20 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
93.21 	access to or use of medical cannabis flower or medical cannabinoid products to the extent 
93.22 	that such use is authorized under sections 342.47 342.51 to 342.59. No facility or provider 
93.23 	listed in this subdivision may prohibit a patient access to or use of medical cannabis flower 
93.24 	or medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug
93.25 	controlled substance pursuant to the federal Uniform Controlled Substances Act. If a federal 
93.26 	regulatory agency, the United States Department of Justice, or the federal Centers for 
93.27 	Medicare and Medicaid Services takes one of the following actions, a facility or provider 
93.28 	may suspend compliance with this paragraph until the regulatory agency, the United States 
93.29 	Department of Justice, or the federal Centers for Medicare and Medicaid Services notifies 
93.30 	the facility or provider that it may resume permitting the use of medical cannabis flower or 
93.31 	medical cannabinoid products within the facility or in the provider's service setting:
93.32 	(1) a federal regulatory agency or the United States Department of Justice initiates 
93.33 	enforcement action against a facility or provider related to the facility's compliance with 
93.34 	the medical cannabis program; or
94.1 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
94.2 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
94.3 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
94.4 	facilities or otherwise prohibits compliance with the medical cannabis program.
94.5 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
94.6 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
94.7 	of medical cannabis flower or medical cannabinoid products while carrying out employment 
94.8 	duties, including providing or supervising care to a patient enrolled in the registry program, 
94.9 	or distribution of medical cannabis flower or medical cannabinoid products to a patient 
94.10 	enrolled in the registry program who resides at or is actively receiving treatment or care at 
94.11 	the facility or from the provider with which the employee or agent is affiliated.

94.12 	EFFECTIVE DATE. This section is effective July 1, 2025.

94.13 	Sec. 100. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended 
94.14 	to read:
94.15 		Subdivision 1.Presumption. There is a presumption that a patient or other person 
94.16 	enrolled in the registry program is engaged in the authorized use or possession of medical 
94.17 	cannabis flower and medical cannabinoid products. This presumption may be rebutted by 
94.18 	evidence that the patient's use of medical cannabis flower or medical cannabinoid products
94.19 	use or possession of medical cannabis flower or medical cannabinoid products by a patient 
94.20 	or other person enrolled in the registry program was not for the purpose of assisting with, 
94.21 	treating, or alleviating the patient's qualifying medical condition or symptoms associated 
94.22 	with the patient's qualifying medical condition.

94.23 	EFFECTIVE DATE. This section is effective July 1, 2025.

94.24 	Sec. 101. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended 
94.25 	to read:
94.26 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the following 
94.27 	are not violations of this chapter or chapter 152:
94.28 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
94.29 	medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting 
94.30 	patient to whom medical cannabis flower or medical cannabinoid products are distributed 
94.31 	under section 342.51, subdivision 5;
95.1 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
95.2 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
95.3 	spouse of a patient enrolled in the registry program; or
95.4 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
95.5 	cannabis paraphernalia by any person while carrying out duties required under sections 
95.6 	342.47 342.51 to 342.60.
95.7 	(b) The Office of Cannabis Management, members of the Cannabis Advisory Council, 
95.8 	Office of Cannabis Management employees, agents or contractors of the Office of Cannabis 
95.9 	Management, and health care practitioners participating in the registry program are not 
95.10 	subject to any civil penalties or disciplinary action by the Board of Medical Practice, the 
95.11 	Board of Nursing, or any business, occupational, or professional licensing board or entity 
95.12 	solely for participating in the registry program either in a professional capacity or as a 
95.13 	patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or 
95.14 	disciplinary action by the Board of Pharmacy when acting in accordance with sections 
95.15 	342.47 342.51 to 342.60 either in a professional capacity or as a patient. Nothing in this 
95.16 	section prohibits a professional licensing board from taking action in response to a violation 
95.17 	of law.
95.18 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
95.19 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
95.20 	any injury, loss of property, personal injury, or death caused by any act or omission while 
95.21 	acting within the scope of office or employment under sections 342.47 342.51 to 342.60.
95.22 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
95.23 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
95.24 	13.09, a violation of this paragraph is a gross misdemeanor.
95.25 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
95.26 	not release data or information about an individual contained in any report or document or 
95.27 	in the registry and must not release data or information obtained about a patient enrolled in 
95.28 	the registry program, except as provided in sections 342.47 342.51 to 342.60. 
95.29 	Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.
95.30 	(f) No information contained in a report or document, contained in the registry, or 
95.31 	obtained from a patient under sections 342.47 342.51 to 342.60 may be admitted as evidence 
95.32 	in a criminal proceeding, unless:
95.33 	(1) the information is independently obtained; or
96.1 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
96.2 	violation of sections 342.47 342.51 to 342.60.
96.3 	(g) Possession of a registry verification or an application for enrollment in the registry 
96.4 	program:
96.5 	(1) does not constitute probable cause or reasonable suspicion;
96.6 	(2) must not be used to support a search of the person or property of the person with a 
96.7 	registry verification or application to enroll in the registry program; and
96.8 	(3) must not subject the person or the property of the person to inspection by any 
96.9 	government agency.

96.10 	EFFECTIVE DATE. This section is effective July 1, 2025.

96.11 	Sec. 102. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended 
96.12 	to read:
96.13 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
96.14 	patient's use of medical cannabis flower or medical cannabinoid products according to 
96.15 	sections 342.47 342.51 to 342.60 is considered the equivalent of the authorized use of a 
96.16 	medication used at the discretion of a health care practitioner and does not disqualify a 
96.17 	patient from needed medical care.

96.18 	EFFECTIVE DATE. This section is effective July 1, 2025.

96.19 	Sec. 103. Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:
96.20 	342.60 APPLIED RESEARCH.
96.21 	The Division of Medical Cannabis office may conduct, or award grants to health care 
96.22 	providers or research organizations to conduct, applied research on the safety and efficacy 
96.23 	of using medical cannabis flower or medical cannabinoid products to treat a specific health 
96.24 	condition. A health care provider or research organization receiving a grant under this section 
96.25 	must provide the office with access to all data collected in applied research funded under 
96.26 	this section. The office may use data from applied research conducted or funded under this 
96.27 	section as evidence to approve additional qualifying medical conditions or additional 
96.28 	allowable forms of medical cannabis.

96.29 	EFFECTIVE DATE. This section is effective July 1, 2025.

97.1 	Sec. 104. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 1, is amended 
97.2 	to read:
97.3 		Subdivision 1.Testing required. (a) Cannabis businesses and hemp businesses shall 
97.4 	not sell or offer for sale cannabis flower, cannabis products, artificially derived cannabinoids, 
97.5 	lower-potency hemp edibles, or hemp-derived consumer products to another cannabis 
97.6 	business or hemp business, or to a customer or patient, or otherwise transfer cannabis flower, 
97.7 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
97.8 	hemp-derived consumer products to another cannabis business or hemp business, unless:
97.9 	(1) a representative sample of the batch of cannabis flower, cannabis products, artificially 
97.10 	derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products 
97.11 	has been tested according to this section and rules adopted under this chapter;
97.12 	(2) the testing was completed by a cannabis testing facility licensed under this chapter
97.13 	or meeting the requirements of paragraph (b); and
97.14 	(3) the tested sample of cannabis flower, cannabis products, artificially derived 
97.15 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products was found 
97.16 	to meet testing standards established by the office.
97.17 	(b) Testing of lower-potency hemp edibles and hemp-derived consumer products that 
97.18 	do not contain intoxicating cannabinoids may be performed by any laboratory that has been 
97.19 	accredited pursuant to standard ISO/IEC 17025 of the International Organization for 
97.20 	Standardization with specific accreditation for cannabis testing.

97.21 	Sec. 105. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended 
97.22 	to read:
97.23 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
97.24 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
97.25 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
97.26 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
97.27 	medical cannabis combination business shall make each batch of cannabis flower, cannabis 
97.28 	products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived 
97.29 	consumer products grown, manufactured, or imported by the cannabis business or hemp 
97.30 	business available to a cannabis testing facility.
97.31 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
97.32 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
97.33 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
98.1 	medical cannabis combination business must disclose all known information regarding 
98.2 	pesticides, fertilizers, solvents, or other foreign materials, including but not limited to 
98.3 	catalysts used in creating artificially derived cannabinoids, applied or added to the batch of 
98.4 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
98.5 	edibles, or hemp-derived consumer products subject to testing. Disclosure must be made 
98.6 	to the cannabis testing facility and must include information about all applications by any 
98.7 	person, whether intentional or accidental.
98.8 	(c) The cannabis testing facility shall select one or more representative samples from 
98.9 	each batch, test the samples for the presence of contaminants, and test the samples for 
98.10 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
98.11 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
98.12 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
98.13 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
98.14 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
98.15 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
98.16 	cannabis business or hemp business any part of the sample that remains after testing.

98.17 	Sec. 106. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended 
98.18 	to read:
98.19 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
98.20 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
98.21 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
98.22 	endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis 
98.23 	cultivator, medical cannabis processor, or medical cannabis combination business and the 
98.24 	cannabis business or hemp business may then sell or transfer the batch of cannabis flower, 
98.25 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
98.26 	hemp-derived consumer products from which the sample was taken to another cannabis 
98.27 	business or hemp business, or offer the cannabis flower, cannabis products, lower-potency 
98.28 	hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a 
98.29 	sample does not meet the applicable testing standards or if the testing facility is unable to 
98.30 	test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which 
98.31 	the sample was taken shall be subject to procedures established by the office for such batches, 
98.32 	including destruction, remediation, or retesting.
98.33 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
98.34 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
99.1 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
99.2 	medical cannabis combination business must maintain the test results for cannabis flower, 
99.3 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
99.4 	hemp-derived consumer products grown, manufactured, or imported by that cannabis 
99.5 	business or hemp business for at least five years after the date of testing.
99.6 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
99.7 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
99.8 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
99.9 	medical cannabis combination business shall make test results maintained by that cannabis 
99.10 	business or hemp business available for review by any member of the public, upon request. 
99.11 	Test results made available to the public must be in plain language.

99.12 	Sec. 107. Minnesota Statutes 2023 Supplement, section 342.62, is amended by adding a 
99.13 	subdivision to read:
99.14 		Subd. 4.Prohibition of sale of certain empty packaging. No person shall sell, offer 
99.15 	for sale, or facilitate the sale of empty packaging that, if used, would be a violation of any 
99.16 	provision of this section. Enforcement of this subdivision is subject to section 8.31.

99.17 	Sec. 108. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended 
99.18 	to read:
99.19 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
99.20 	products that consist of hemp plant parts sold to customers or patients must have affixed 
99.21 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
99.22 	label that contains at least the following information:
99.23 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
99.24 	cannabis cultivator, medical cannabis cultivator combination business, or industrial hemp 
99.25 	grower where the cannabis flower or hemp plant part was cultivated;
99.26 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
99.27 	container;
99.28 	(3) the batch number;
99.29 	(4) the cannabinoid profile;
99.30 	(5) a universal symbol established by the office indicating that the package or container 
99.31 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
99.32 	hemp-derived consumer product;
100.1 	(6) verification that the cannabis flower or hemp plant part was tested according to 
100.2 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
100.3 	standards;
100.4 	(7) the maximum dose, quantity, or consumption that may be considered medically safe 
100.5 	within a 24-hour period information on the usage of the cannabis flower or hemp-derived 
100.6 	consumer product;
100.7 	(8) the following statement: "Keep this product out of reach of children."; and
100.8 	(9) any other statements or information required by the office.

100.9 	Sec. 109. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended 
100.10 	to read:
100.11 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
100.12 	lower-potency hemp edibles, hemp-derived consumer products other than products subject 
100.13 	to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived 
100.14 	topical products sold to customers or patients must have affixed to the packaging or container 
100.15 	of the cannabis product a label that contains at least the following information:
100.16 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
100.17 	cannabis cultivator, medical cannabis cultivator combination business, or industrial hemp 
100.18 	grower that cultivated the cannabis flower or hemp plant parts used in the cannabis product, 
100.19 	lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid 
100.20 	product;
100.21 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
100.22 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis processor
100.23 	combination business, or industrial hemp grower that manufactured the cannabis concentrate, 
100.24 	hemp concentrate, or artificially derived cannabinoid and, if different, the name and license 
100.25 	number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, 
100.26 	lower-potency hemp edible manufacturer, or medical cannabis processor combination 
100.27 	business that manufactured the product;
100.28 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
100.29 	hemp-derived consumer product in the package or container;
100.30 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
100.31 	product;
100.32 	(5) the batch number;
101.1 	(6) the serving size;
101.2 	(7) the cannabinoid profile per serving and in total;
101.3 	(8) a list of ingredients;
101.4 	(9) a universal symbol established by the office indicating that the package or container 
101.5 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
101.6 	hemp-derived consumer product;
101.7 	(10) a warning symbol developed by the office in consultation with the commissioner 
101.8 	of health and the Minnesota Poison Control System that:
101.9 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
101.10 	(ii) is in a highly visible color;
101.11 	(iii) includes a visual element that is commonly understood to mean a person should 
101.12 	stop;
101.13 	(iv) indicates that the product is not for children; and
101.14 	(v) includes the phone number of the Minnesota Poison Control System;
101.15 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
101.16 	consumer product, or medical cannabinoid product was tested according to section 342.61 
101.17 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
101.18 	or medical cannabinoid product complies with the applicable standards;
101.19 	(12) the maximum dose, quantity, or consumption that may be considered medically 
101.20 	safe within a 24-hour period information on the usage of the product;
101.21 	(13) the following statement: "Keep this product out of reach of children."; and
101.22 	(14) any other statements or information required by the office.
101.23 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
101.24 	hemp edibles that are imported into the state provided that if those requirements provide 
101.25 	consumers with information that is substantially similar to the information described in 
101.26 	paragraph (a).

102.1 	Sec. 110. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended 
102.2 	to read:
102.3 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
102.4 	cannabis retailer, medical cannabis retailer, or medical cannabis combination business must 
102.5 	provide customers and patients with the following information:
102.6 	(1) factual information about impairment effects and the expected timing of impairment 
102.7 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
102.8 	lower-potency hemp edibles, and hemp-derived consumer products;
102.9 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
102.10 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
102.11 	hemp edibles, and hemp-derived consumer products;
102.12 	(3) resources customers and patients may consult to answer questions about cannabis 
102.13 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
102.14 	products, and any side effects and adverse effects;
102.15 	(4) contact information for the poison control center and a safety hotline or website for 
102.16 	customers to report and obtain advice about side effects and adverse effects of cannabis 
102.17 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
102.18 	products;
102.19 	(5) substance use disorder treatment options; and
102.20 	(6) any other information specified by the office.
102.21 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical 
102.22 	cannabis retailer combination business may include the information described in paragraph 
102.23 	(a) on the label affixed to the packaging or container of cannabis flower, cannabis products, 
102.24 	lower-potency hemp edibles, and hemp-derived consumer products by:
102.25 	(1) posting the information in the premises of the cannabis microbusiness, cannabis 
102.26 	mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination 
102.27 	business; or
102.28 	(2) providing the information on a separate document or pamphlet provided to customers 
102.29 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
102.30 	hemp edible, or a hemp-derived consumer product.

103.1 	Sec. 111. Minnesota Statutes 2023 Supplement, section 342.64, subdivision 1, is amended 
103.2 	to read:
103.3 		Subdivision 1.Limitations applicable to all advertisements. Cannabis businesses, 
103.4 	hemp businesses, and other persons shall not publish or cause to be published an 
103.5 	advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis product, 
103.6 	a lower-potency hemp edible, or a hemp-derived consumer product in a manner that:
103.7 	(1) contains false or misleading statements;
103.8 	(2) contains unverified claims about the health or therapeutic benefits or effects of 
103.9 	consuming cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
103.10 	hemp-derived consumer product;
103.11 	(3) promotes the overconsumption of cannabis flower, a cannabis product, a 
103.12 	lower-potency hemp edible, or a hemp-derived consumer product;
103.13 	(4) depicts a person under 21 years of age consuming cannabis flower, a cannabis product, 
103.14 	a lower-potency hemp edible, or a hemp-derived consumer product; or
103.15 	(5) includes an image designed or likely to appeal to individuals under 21 years of age, 
103.16 	including cartoons, toys, animals, candy, dessert, or children, or any other likeness to images, 
103.17 	characters, or phrases that is designed to be appealing to individuals under 21 years of age 
103.18 	or encourage consumption by individuals under 21 years of age; and
103.19 	(6) contains an image of alcohol or a person or persons consuming alcohol; and
103.20 	(7) does not contain a warning as specified by the office regarding impairment and health 
103.21 	risks.

103.22 	Sec. 112. Minnesota Statutes 2023 Supplement, section 342.73, subdivision 4, is amended 
103.23 	to read:
103.24 		Subd. 4.Loan financing grants. (a) The CanGrow revolving loan account is established 
103.25 	in the special revenue fund. Money in the account, including interest, is appropriated to the 
103.26 	commissioner office to make loan financing grants under the CanGrow program.
103.27 	(b) The office must award grants to nonprofit corporations through a competitive grant 
103.28 	process.
103.29 	(c) To receive grant money, a nonprofit corporation must submit a written application 
103.30 	to the office using a form developed by the office.
104.1 	(d) In awarding grants under this subdivision, the office shall give weight to whether 
104.2 	the nonprofit corporation:
104.3 	(1) has a board of directors that includes individuals experienced in agricultural business 
104.4 	development;
104.5 	(2) has the technical skills to analyze projects;
104.6 	(3) is familiar with other available public and private funding sources and economic 
104.7 	development programs;
104.8 	(4) can initiate and implement economic development projects;
104.9 	(5) can establish and administer a revolving loan account; and
104.10 	(6) has established relationships with communities where long-term residents are eligible 
104.11 	to be social equity applicants.
104.12 	The office shall make grants that will help farmers enter the legal cannabis industry 
104.13 	throughout the state.
104.14 	(e) A nonprofit corporation that receives grants under the program must:
104.15 	(1) establish an office-certified revolving loan account for the purpose of making eligible 
104.16 	loans; and
104.17 	(2) enter into an agreement with the office that the office shall fund loans that the 
104.18 	nonprofit corporation makes to farmers entering the legal cannabis industry. The office shall 
104.19 	review existing agreements with nonprofit corporations every five years and may renew or 
104.20 	terminate an agreement based on that review. In making this review, the office shall consider, 
104.21 	among other criteria, the criteria in paragraph (d).

104.22 	Sec. 113. Minnesota Statutes 2023 Supplement, section 342.80, is amended to read:
104.23 	342.80 LAWFUL ACTIVITIES.
104.24 	(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing, 
104.25 	and selling of cannabis flower, cannabis products, artificially derived cannabinoids, 
104.26 	lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis 
104.27 	business or hemp business in conformity with the rights granted by a cannabis business 
104.28 	license or hemp business license is lawful and may not be the grounds for the seizure or 
104.29 	forfeiture of property, arrest or prosecution, or search or inspections except as provided by 
104.30 	this chapter.
105.1 	(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness, 
105.2 	cannabis retailer, medical cannabis combination business, or lower-potency hemp edible 
105.3 	retailer who sells or otherwise transfers cannabis flower, cannabis products, lower-potency 
105.4 	hemp edibles, or hemp-derived consumer products to a person under 21 years of age is not 
105.5 	subject to arrest, prosecution, or forfeiture of property if the person complied with section 
105.6 	342.27, subdivision 4, and any rules promulgated pursuant to this chapter.

105.7 	Sec. 114. Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to 
105.8 	read:

105.9 	EFFECTIVE DATE. This section is effective July 1, 2023, except for subdivision 3, 
105.10 	which is effective March 1, 2025.

105.11 	Sec. 115. Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to 
105.12 	read:

105.13 	EFFECTIVE DATE. This section is effective March July 1, 2025.

105.14 	Sec. 116. Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to 
105.15 	read:

105.16 	EFFECTIVE DATE. This section is effective March 1, 2025 the day following final 
105.17 	enactment.

105.18 	Sec. 117. Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to 
105.19 	read:

105.20 	EFFECTIVE DATE. This section is effective March July 1, 2025.

105.21 	Sec. 118. Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to 
105.22 	read:

105.23 	EFFECTIVE DATE. This section is effective March July 1, 2025.

105.24 	Sec. 119. Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to 
105.25 	read:

105.26 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.1 	Sec. 120. Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to 
106.2 	read:

106.3 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.4 	Sec. 121. Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to 
106.5 	read:

106.6 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.7 	Sec. 122. Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to 
106.8 	read:

106.9 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.10 	Sec. 123. Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to 
106.11 	read:

106.12 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.13 	Sec. 124. Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to 
106.14 	read:

106.15 	EFFECTIVE DATE. This section is effective March July 1, 2025.

106.16 	Sec. 125. Laws 2023, chapter 63, article 6, section 10, the effective date, is amended to 
106.17 	read:

106.18 	EFFECTIVE DATE. This section is effective March July 1, 2025 2024.

106.19 	Sec. 126. Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to 
106.20 	read:

106.21 	EFFECTIVE DATE. Paragraph (a) is effective March December 1, 2025. Paragraph 
106.22 	(b) is effective August 1, 2023. Paragraph (c) is effective July 1, 2023.

106.23 	Sec. 127. EMPLOYEE TRANSFER.
 106.24 	(a) The powers and duties of the Department of Health with respect to the sale of certain 
106.25 	cannabinoid products under Minnesota Statutes, section 151.72, are transferred to the Office 
106.26 	of Cannabis Management under Minnesota Statutes, section 15.039.
107.1 	(b) The following protections shall apply to employees who are transferred from the 
107.2 	Department of Health to the Office of Cannabis Management:
107.3 	(1) the employment status and job classification of a transferred employee shall not be 
107.4 	altered as a result of the transfer;
107.5 	(2) transferred employees who were represented by an exclusive representative prior to 
107.6 	the transfer shall continue to be represented by the same exclusive representative after the 
107.7 	transfer;
107.8 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
107.9 	continue in full force and effect for such transferred employees after the transfer;
107.10 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
107.11 	employees about any proposed changes affecting or relating to the transferred employees' 
107.12 	terms and conditions of employment to the extent such changes are not addressed in the 
107.13 	applicable collective bargaining agreement; and
107.14 	(5) for an employee in a temporary unclassified position transferred to the Office of 
107.15 	Cannabis Management, the total length of time that the employee has served in the 
107.16 	appointment shall include all time served in the appointment at the transferring agency and 
107.17 	the time served in the appointment at the Office of Cannabis Management. An employee 
107.18 	in a temporary unclassified position who was hired by a transferring agency through an 
107.19 	open competitive selection process in accordance with a policy enacted by Minnesota 
107.20 	Management and Budget shall be considered to have been hired through such process after 
107.21 	the transfer.

107.22 	EFFECTIVE DATE. This section is effective July 1, 2024.

107.23 	Sec. 128. TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
 107.24 	The Department of Health shall transfer all data, including not public data as defined in 
107.25 	Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
107.26 	complaints involving alleged violations of Minnesota Statutes 2023 Supplement, section 
107.27 	151.72, as well as registration data collected under Minnesota Statutes 2023 Supplement, 
107.28 	section 151.72, subdivision 5b, to the Office of Cannabis Management. The Department of 
107.29 	Health and the Office of Cannabis Management shall ensure that the transfer takes place in 
107.30 	a manner and on a schedule that prioritizes public health.

107.31 	EFFECTIVE DATE. This section is effective July 1, 2024.

108.1 	Sec. 129. TRANSFER OF MEDICAL PROGRAM.
 108.2 	(a) Notwithstanding the data's classification under Minnesota Statutes, chapter 13, the 
108.3 	Office of Cannabis Management may access data maintained by the commissioner of health 
108.4 	related to the responsibilities transferred under Minnesota Statutes, section 342.02, 
108.5 	subdivision 3. Data sharing authorized by this subdivision includes not public data as defined 
108.6 	in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
108.7 	complaints involving any alleged violation of Minnesota Statutes, sections 152.22 to 152.37, 
108.8 	by a medical cannabis manufacturer. Data sharing under this paragraph further includes 
108.9 	data in patient files maintained by the commissioner and the health care practitioner and 
108.10 	data submitted to or by a medical cannabis manufacturer classified as private data on 
108.11 	individuals, as defined in Minnesota Statutes, section 13.02, subdivision 12, or nonpublic 
108.12 	data, as defined in Minnesota Statutes, section 13.02, subdivision 9. Any data shared under 
108.13 	this section retain the data's classification from the agency holding the data. The office must 
108.14 	establish written procedures to ensure that only individuals authorized by law may enter, 
108.15 	update, or access data classified as nonpublic or private data on individuals. An authorized 
108.16 	individual's ability to enter, update, or access not public data must correspond to the official 
108.17 	duties or training level of the individual and to the statutory authorization granting access 
108.18 	for that purpose. All queries and responses, and all actions in which not public data are 
108.19 	entered, updated, accessed, shared, or disseminated, must be recorded in a data audit trail. 
108.20 	Data contained in the audit trail have the same classification as the underlying data tracked 
108.21 	by the audit trail.
108.22 	(b) All rules adopted by the commissioner of health pursuant to Minnesota Statutes, 
108.23 	sections 152.22 to 152.37, including but not limited to Minnesota Rules, chapter 4770, 
108.24 	remain effective and shall be enforced until amended or repealed consistent with Minnesota 
108.25 	Statutes, section 15.039, subdivision 3.
108.26 	(c) The director of the Office of Cannabis Management may use the good cause exempt 
108.27 	rulemaking process under Minnesota Statutes, section 14.388, subdivision 1, clauses (3) 
108.28 	and (4), to copy and adopt any portions of Minnesota Rules, parts 4770.0100 to 4770.4030, 
108.29 	that are necessary to effectuate the transfer of authority granted under Minnesota Statutes, 
108.30 	section 342.02, subdivision 3. The commissioner may make technical changes and any 
108.31 	changes necessary to conform with the transfer of authority. Any change to the rules that 
108.32 	is not authorized under this paragraph must be adopted according to Minnesota Statutes, 
108.33 	sections 14.001 to 14.366.
108.34 	(d) Unless otherwise specified in this section or Minnesota Statutes, section 342.02, 
108.35 	subdivision 3, transfer of the powers, duties, rights, obligations, and other authority imposed 
109.1 	by law on the Department of Health with respect to the medical cannabis program under 
109.2 	Minnesota Statutes 2022, sections 152.22 to 152.37, to the Office of Cannabis Management 
109.3 	is subject to Minnesota Statutes, section 15.039.

109.4 	Sec. 130. REPEALER.
 109.5 	(a) Minnesota Statutes 2022, sections 152.22, subdivision 3; and 152.36, are repealed.
109.6 	(b) Minnesota Statutes 2023 Supplement, sections 342.01, subdivision 28; 342.18, 
109.7 	subdivision 1; 342.27, subdivision 13; and 342.29, subdivision 9, are repealed.
109.8 	(c) Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; and 342.50,
109.9 	are repealed.
109.10 	(d) Laws 2023, chapter 63, article 7, sections 4; and 6, are repealed.

109.11 	EFFECTIVE DATE. Paragraphs (a), (b), and (d) are effective the day following final 
109.12 	enactment. Paragraph (c) is effective July 1, 2025.

109.13 	Sec. 131. EFFECTIVE DATE.
 109.14 	Except as otherwise provided, this act is effective the day following final enactment.

APPENDIX 

Repealed Minnesota Statutes: H4757-3 

152.22 DEFINITIONS.Subd. 3.Disqualifying felony offense. 
"Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis. 

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH.Subdivision 1.Task force on medical cannabis therapeutic research. 
(a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members: 

(1) two members of the house of representatives, one selected by the speaker of the house, the other selected by the minority leader; 

(2) two members of the senate, one selected by the majority leader, the other selected by the minority leader; 

(3) four members representing consumers or patients enrolled in the registry program, including at least two parents of patients under age 18; 

(4) four members representing health care providers, including one licensed pharmacist; 

(5) four members representing law enforcement, one from the Minnesota Chiefs of Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and Peace Officers Association, and one from the Minnesota County Attorneys Association; 

(6) four members representing substance use disorder treatment providers; and 

(7) the commissioners of health, human services, and public safety. 

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed by the governor under the appointment process in section 15.0597. Members shall serve on the task force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014, and the commissioner of health shall convene the first meeting of the task force by August 1, 2014. 

(c) There shall be two cochairs of the task force chosen from the members listed under paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected by the majority leader of the senate. The authority to convene meetings shall alternate between the cochairs. 

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall receive expenses as provided in section 15.059, subdivision 6. 

Subd. 1a.Administration. 
The commissioner of health shall provide administrative and technical support to the task force. 

Subd. 2.Impact assessment. 
The task force shall hold hearings to evaluate the impact of the use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp, including, but not limited to: 

(1) program design and implementation; 

(2) the impact on the health care provider community; 

(3) patient experiences; 

(4) the impact on the incidence of substance abuse; 

(5) access to and quality of medical cannabis, hemp, and medical cannabis products; 

(6) the impact on law enforcement and prosecutions; 

(7) public awareness and perception; and 

(8) any unintended consequences. 

Subd. 3.Cost assessment. 
By January 15 of each year, beginning January 15, 2015, and ending January 15, 2019, the commissioners of state departments impacted by the medical cannabis therapeutic research study shall report to the cochairs of the task force on the costs incurred by each department on implementing sections 152.22 to 152.37. The reports must compare actual costs to the estimated costs of implementing these sections and must be submitted to the task force on medical cannabis therapeutic research. 

Subd. 4.Reports to the legislature. 
(a) The cochairs of the task force shall submit the following reports to the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health and human services, public safety, judiciary, and civil law: 

(1) by February 1, 2015, a report on the design and implementation of the registry program; and every two years thereafter, a complete impact assessment report; and 

(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed cost assessment. 

(b) The task force may make recommendations to the legislature on whether to add or remove conditions from the list of qualifying medical conditions. 

Subd. 5.No expiration. 
The task force on medical cannabis therapeutic research does not expire. 

342.01 DEFINITIONS.Subd. 28.Division of Medical Cannabis. 
"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program. 

342.18 LICENSE SELECTION CRITERIA.Subdivision 1.Market stability. 
The office shall issue the necessary number of licenses in order to ensure the sufficient supply of cannabis flower and cannabis products to meet demand, provide market stability, ensure a competitive market, and limit the sale of unregulated cannabis flower and cannabis products. 

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.Subd. 13.Adult-use and medical cannabis; colocation. 
(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises. 

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient. 

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.Subd. 9.Medical cannabis endorsement. 
A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office. 

342.47 MEDICAL CANNABIS BUSINESS LICENSES.Subdivision 1.License types. 
(a) The office shall issue the following types of medical cannabis business licenses: 

(1) medical cannabis cultivator; 

(2) medical cannabis processor; 

(3) medical cannabis retailer; and 

(4) medical cannabis combination business license. 

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses. 

Subd. 2.Multiple licenses; limits. 
(a) Except as provided in subdivision 3, a person, cooperative, or business holding: 

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; 

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or 

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses. 

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business. 

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold. 

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business. 

Subd. 3.Medical cannabis combination business license. 
(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business. 

(b) A person or business may only hold one medical cannabis combination license. 

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.
In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office: 

(1) for medical cannabis cultivator license applicants: 

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and 

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought; 

(2) for medical cannabis processor license applicants: 

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration; 

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and 

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought; 

(3) for medical cannabis retailer license applicants: 

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business; 

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and 

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or 

(4) for medical cannabis combination license applicants: 

(i) the information required under clauses (1) to (3); and 

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3. 

342.49 MEDICAL CANNABIS CULTIVATORS.
(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office. 

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25. 

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity. 

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023. 

342.50 MEDICAL CANNABIS PROCESSORS.
(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and 

(7) perform other actions approved by the office. 

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements. 

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity. 

Repealed Minnesota Session Laws: H4757-3 

Laws 2023, chapter 63, article 7, section 4
Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT. 
(a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. 

(b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. 

(c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. 

(d) This section shall expire on March 1, 2025. 

EFFECTIVE DATE. 
This section is effective the day following final enactment. 

Laws 2023, chapter 63, article 7, section 6
Sec. 6. REPEALER. Minnesota Statutes 2022, section 151.72, is repealed.
EFFECTIVE DATE. 
This section is effective March 1, 2025.